186
PHYSIOTHERAPY IN THE PHYSIOTHERAPY IN THE MANAGEMENT OF MANAGEMENT OF PARKINSON PARKINSON·S DISEASE ·S DISEASE Presented by Presented by IROGUE.EGHOSA. KENNEDY IROGUE.EGHOSA. KENNEDY MRH/2005/024 MRH/2005/024 Student Physiotherapis t Student Physiotherapis t Department Of Medical Rehabilitation Department Of Medical Rehabilitation Faculty of Basic Medical Science,O.A.U Ile Ife Faculty of Basic Medical Science,O.A.U Ile Ife SPECIAL TOPIC SEMINAR MRH 507 SPECIAL TOPIC SEMINAR MRH 507

Irogue Seminar Presentation October 2010

Embed Size (px)

Citation preview

Page 1: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 1/186

PHYSIOTHERAPY IN THEPHYSIOTHERAPY IN THE

MANAGEMENT OFMANAGEMENT OFPARKINSONPARKINSON·S DISEASE·S DISEASE

Presented byPresented byIROGUE.EGHOSA. KENNEDY IROGUE.EGHOSA. KENNEDY 

MRH/2005/024MRH/2005/024

Student PhysiotherapistStudent PhysiotherapistDepartment Of Medical RehabilitationDepartment Of Medical Rehabilitation

Faculty of Basic Medical Science,O.A.U Ile IfeFaculty of Basic Medical Science,O.A.U Ile Ife

SPECIAL TOPIC SEMINAR MRH 507SPECIAL TOPIC SEMINAR MRH 507

Page 2: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 2/186

PRESENTATION OBJECTIVESPRESENTATION OBJECTIVES

 To define To define key issues in the management of key issues in the management of Parkinson·sParkinson·s disease (PD) relating disease (PD) relating to physiotherapy to physiotherapy treatmenttreatment..

 To To inform our knowledge of currentinform our knowledge of current evidenceevidence--

basedbased recommendations of physiotherapy inrecommendations of physiotherapy inParkinson's disease.Parkinson's disease.

Page 3: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 3/186

OUTLINEOUTLINE DefinitionDefinition

ClassificationClassification

Background /Background / History History 

DiagnosisDiagnosis

Differential diagnosisDifferential diagnosis Pathophysiology Pathophysiology 

Epidemiology Epidemiology 

Clinical features /Clinical features / presentation.presentation.

Prognostic factorPrognostic factor

ManagementsManagements of of Parkinson·sParkinson·s diseasedisease

Medical therapy Medical therapy 

Surgical therapy Surgical therapy 

Physiotherapy Physiotherapy 

Page 4: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 4/186

Overview of Parkinson·s diseaseOverview of Parkinson·s disease

 Also known as : Also known as :

Paralysis agitansParalysis agitans

Shaking palsy.Shaking palsy.

Page 5: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 5/186

 Why Parkinson·s disease ? Why Parkinson·s disease ?

 The The evidenceevidence availableavailable toto practitioners practitioners with with regardsregards toto appropriateappropriate

 physiotherapy physiotherapy interventionintervention forfor people people with with Parkinson'sParkinson's diseasedisease upup

tilltill thethe RESCUERESCUE ProjectProject randomisedrandomised controlcontrol trialtrial hashas eithereither beenbeen

of of poor poor qualityquality oror absentabsent.. PhysiotherapyPhysiotherapy hashas thereforetherefore hadhad toto relyrely

onon unsubstantiatedunsubstantiated anecdotalanecdotal reportsreports fromfrom professionals, professionals, people people

 with with Parkinson·sParkinson·s oror carerscarers regardingregarding thethe effectivenesseffectiveness of of inputinput.. An An

effectivenesseffectiveness bulletinbulletin onon neurologicalneurological conditionsconditions (Chartered(Chartered

SocietySociety of of PhysiotherapyPhysiotherapy 20012001)) concludedconcluded thatthat manymany areasareas of  of 

 physiotherapy physiotherapy hadhad yet yet toto bebe sufficientlysufficiently evaluatedevaluated..

Page 6: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 6/186

InIn neurologicalneurological problems, problems, Parkinson·sParkinson·s diseasedisease isis thethe

mostmost commoncommon disorderdisorder leadingleading toto gaitgait disturbancedisturbance andand

fallsfalls (Stolze(Stolze etet al,al, 20052005))..

DespiteDespite advancesadvances inin pharmacological pharmacological treatmentstreatments andand

surgicalsurgical techniques,techniques, gaitgait andand balancebalance deficitsdeficits stillstill

 persist persist andand areare associatedassociated with with lossloss of of independence,independence,

immobilityimmobility andand highhigh costcost forfor healthcarehealthcare systemssystems..

(Grimbergen(Grimbergen etet alal..,, 20042004))..

OtherOther mobilitymobility deficits,deficits, includesincludes difficultiesdifficulties with with

transferstransfers andand posture posture..

Page 7: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 7/186

 This frequently leads to loss of independence, (fear of) falls, This frequently leads to loss of independence, (fear of) falls,

injuries, and inactivity, resulting in social isolation and aninjuries, and inactivity, resulting in social isolation and an

increased risk of osteoporosis or cardiovascular disease. (Bloem,increased risk of osteoporosis or cardiovascular disease. (Bloem,

et al., 2001; Garrett, et al., 2004).et al., 2001; Garrett, et al., 2004).

Consequently, costs increase (Pressley, et al., 2003) and qualityConsequently, costs increase (Pressley, et al., 2003) and quality

of life decreases (Schrag, et al., 2000).of life decreases (Schrag, et al., 2000).

 These mobility deficits are difficult to treat with drugs or These mobility deficits are difficult to treat with drugs or

neurosurgery. (Schrag et al., 2002; Bloem et al., 1996)neurosurgery. (Schrag et al., 2002; Bloem et al., 1996)

Physical therapy is often prescribed next to medical treatmentPhysical therapy is often prescribed next to medical treatment

(Keus, et al., 2004). Therefore, the awareness and application of (Keus, et al., 2004). Therefore, the awareness and application of 

rehabilitation approaches that work in conjunction with currentrehabilitation approaches that work in conjunction with current

treatment is important to manage thesetreatment is important to manage these problems. problems.

Page 8: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 8/186

However, there is presently the first evidenceHowever, there is presently the first evidence--basedbased

international guideline for physical therapy in Parkinson·s diseaseinternational guideline for physical therapy in Parkinson·s disease

developed according to international standards of guidelinedeveloped according to international standards of guideline

development with practical recommendations graded accordingdevelopment with practical recommendations graded according

to scientific evidence.to scientific evidence.

 This is the KNGF guidelines for physical therapy in patients This is the KNGF guidelines for physical therapy in patients

 with Parkinson·s disease. The guidelines identify six core areas of  with Parkinson·s disease. The guidelines identify six core areas of 

 physiotherapy practice: physical capacity and prevention of  physiotherapy practice: physical capacity and prevention of 

inactivity; transfers; gait; posture; reaching and grasping; andinactivity; transfers; gait; posture; reaching and grasping; and

balance and falls. To this guideline we based currentbalance and falls. To this guideline we based current

 physiotherapy management on Parkinson·s disease physiotherapy management on Parkinson·s disease

Page 9: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 9/186

InIn Africa, Africa, NigeriaNigeria toto bebe precise precise aa recentrecent researchresearch onon thethe

clinicalclinical profile profile of of Parkinson·sParkinson·s diseasedisease patients patients showsshows thatthat itit

isis thethe samesame with with otherother population population butbut characterisedcharacterised byby

delayeddelayed presentation presentation asas hashas beenbeen reportedreported inin otherother

developingdeveloping countriescountries.. Young Young--onsetonset Parkinson·sParkinson·s diseasediseaseoccursoccurs butbut maymay bebe lessless commonlycommonly encounteredencountered andand

frequencyfrequency of of positive positive familyfamily historyhistory isis lowerlower thanthan inin

 western western population population (Okubadejo(Okubadejo etet alal..,, 20102010))..physiotherapy physiotherapy

isis thereforetherefore advocatedadvocated inin combinationcombination with with optimaloptimal timingtiming

of of medications(Morrismedications(Morris etet alal..,,19981998))

Page 10: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 10/186

DEFINITIONDEFINITION

MarsdenMarsden ((19941994)) defineddefined parkinson·s parkinson·s diseasedisease asas aa

clinicalclinical syndromesyndrome of of movementmovement consistingconsisting of of tremortremor atat

rest,rest, rigidity,rigidity, elementselements of of bradykinesiabradykinesia (slowness(slowness of of 

movement),movement), akinesia(lossakinesia(loss of of movement)movement) andand postural postural

abnormalitiesabnormalities associatedassociated with with aa distinctivedistinctive pathology pathology

consistingconsisting of of degenerationdegeneration of of pigmented pigmented brainbrain stemstem

nuclei,nuclei, includingincluding thethe dopaminergicdopaminergic SubstantiaSubstantia NigraNigra

ParPar Compacta(SNPC)Compacta(SNPC) with with thethe presence presence of of lewylewy

bodiesbodies inin thethe remainingremaining nervenerve cellscells..

Page 11: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 11/186

HISTORY/BACKGROUNDHISTORY/BACKGROUND InIn 18171817,, James James ParkinsonParkinson firstfirst describeddescribed thethe

ParkinsonParkinson diseasedisease.. HisHis descriptiondescription of of thethe diseasedisease

 was was asas followsfollows..

InvoluntaryInvoluntary tremuloustremulous motion,motion, with with lessenedlessened

muscularmuscular power power inin parts parts notnot inin actionaction andand eveneven when when

supportedsupported with with aa propensity propensity toto bendbend thethe trunk trunk forwardforward andand toto pass pass fromfrom aa walking walking toto runningrunning paces paces;;

thethe sensessenses andand intellectsintellects beingbeing uninjureduninjured..

Page 12: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 12/186

In 1867, Trousseau noted the muscular rigidity andIn 1867, Trousseau noted the muscular rigidity and

cog wheeling appearance.cog wheeling appearance.

In 1877, Charcot named first disease as Parkinson·sIn 1877, Charcot named first disease as Parkinson·s

disease as he noted the absence of facial expressiondisease as he noted the absence of facial expression

(masked faces) as a feature of the disorder.(masked faces) as a feature of the disorder.

In 1880, Charcot listed PD as the 5In 1880, Charcot listed PD as the 5thth most commonmost common

disease.disease.

In 1888, Gower noted that, the malady usuallyIn 1888, Gower noted that, the malady usually

commences after 40years of age.commences after 40years of age.

Page 13: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 13/186

InIn 18981898,, PurvesPurves Stewart,Stewart, recognizedrecognized distinctdistinct

 positioning positioning of of thethe feet,feet, usuallyusually provoked provoked byby exerciseexercise

butbut occasionallyoccasionally relievedrelieved byby walking walking andand which which couldcould

bebe thethe firstfirst symptomsymptom of of thethe maladymalady..

InIn 19131913,, lewylewy firstfirst describeddescribed thethe concentricconcentric hyalinehyalinecytoplasmiccytoplasmic inclusioninclusion andand calledcalled itit asas lewylewy bodybody.. ItIt isis

observedobserved inin thethe nucleusnucleus of of substantiasubstantia innominatainnominata..

InIn 19191919,, Tretiakoff  Tretiakoff was was thethe firstfirst toto observeobserve thethe

characteristiccharacteristic lesionslesions of of substantiasubstantia nigranigra ii..ee depletiondepletion

of of pigmented pigmented cellscells..

Page 14: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 14/186

InIn 19371937,, HasslerHassler describeddescribed thethe anatomyanatomy of of substantiasubstantia

nigranigra andand inin 19381938,, noticednoticed pathological pathological processes processes of of PDPD

forfor thethe ventrolateral ventrolateral pars pars compactacompacta cellcell groupgroup..

InIn 19571957,, CarlsonCarlson showedshowed thatthat cerebralcerebral dopaminedopamine was was

concentratedconcentrated inin thethe striatumstriatum..

InIn 19601960,, EhingerEhinger andand HonykiewiczHonykiewicz demonstrateddemonstrated thatthat inin

PD,PD, dopaminedopamine was was markedlymarkedly reducedreduced inin thethe substantiasubstantia

NigraNigra caudatecaudate nucleusnucleus andand putamen putamen..

InIn 19671967,, CotziasCotzias showsshows thethe clinicalclinical benefitsbenefits of of highhigh dosedose

of of levolevo--dopadopa inin chronicchronic patients patients with with PDPD..

Page 15: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 15/186

CLASSIFICATIONCLASSIFICATION BASED ONBASED ON

 AETIOLOGY  AETIOLOGY 

PrimaryPrimary oror idiopathicidiopathic Parkinson·sParkinson·s diseasedisease

SecondarySecondary oror acquiredacquired oror symptomaticsymptomatic

Parkinson·sParkinson·s diseasedisease

Parkinson·sParkinson·s plus plus syndromesyndrome.. (adapted(adapted fromfromFahnFahn andand Jankovic Jankovic 19921992))

Page 16: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 16/186

PRIMARY OR IDIOPATHICPRIMARY OR IDIOPATHIC

PARKINSON·S DISEASEPARKINSON·S DISEASE

ItIt is a progressive, disabling,is a progressive, disabling, primary primary

neurodegenerativeneurodegenerative disorder. There are fourdisorder. There are four signs:signs:

Rest tremorRest tremor

RigidityRigidity

BradykinesiaBradykinesia

Postural instabilityPostural instability

((The first three are together called the classical triad) The first three are together called the classical triad)

Page 17: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 17/186

SECONDARY OR SYMPTOMATIC OR SECONDARY OR SYMPTOMATIC OR 

 ACQUIRED PARKINSONISM ACQUIRED PARKINSONISM

ItIt isis thethe collectivecollective termterm forfor aa groupgroup of of conditionsconditions thatthat

indicateindicate PDPD asas well well asas severalseveral otherother degenerativedegenerative brainbrain

disordersdisorders.. The The signssigns andand symptomssymptoms includesincludes thethe fourfour

cardinalcardinal signssigns of of PDPD.. ParkinsonParkinson resultsresults fromfrom aa variety variety

of of causescauses thatthat includeinclude infections,infections, toxins,toxins, drugs,drugs, vascular vascular lesions,lesions, tumortumor andand traumatrauma.. ((neuropepticneuropeptic

drugsdrugs areare consideredconsidered toto bebe thethe commonestcommonest causecause of of 

secondarysecondary ParkinsonParkinson today)today)

Page 18: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 18/186

PARKINSONPARKINSON--PLUS SYNDROME OR PLUS SYNDROME OR 

PARKINSONISM SYNDROMEPARKINSONISM SYNDROME

ItIt constitutesconstitutes of of heterogeneousheterogeneous groupgroup of  of 

multifacetedmultifaceted disorderdisorder characterisedcharacterised byby

 parkinsonia parkinsonia features,features, with with various various combinationscombinations

of of pyramidal, pyramidal, cerebella,cerebella, andand autonomicautonomic

dysfunctionsdysfunctions.. (The(The mostmost commoncommon formform of  of 

ParkinsonismParkinsonism seenseen byby neurologistsneurologists todaytoday isis thethe

idiopathicidiopathic variety variety of of Parkinson·sParkinson·s disease)disease)..

Page 19: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 19/186

ExamplesExamples of Parkinsonof Parkinson--plus syndrome are: plus syndrome are:

1 )1 ) PROGRESSIVE SUPRANUCLEAR PALSY:PROGRESSIVE SUPRANUCLEAR PALSY:

EarlyEarly postural postural instabilityinstability andand fallsfalls Vertical gaze palsy Vertical gaze palsy

Rigidity of trunk Rigidity of trunk 

Speech and swallowing problemSpeech and swallowing problem Unusual tremorUnusual tremor

Symmetrical onsetSymmetrical onset

Page 20: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 20/186

Examples of ParkinsonExamples of Parkinson--plus syndrome: plus syndrome:

2 )2 ) MULTIPLE SYSTEMIC ATROPHY MULTIPLE SYSTEMIC ATROPHY 

EarlyEarly autonomic features (postural BP decrease andautonomic features (postural BP decrease and

bladder dysfunctionbladder dysfunction))

Cerebella pyramidalCerebella pyramidal signsign

Rigidity>tremorsRigidity>tremors

3)3) LE W Y BODY LE W Y BODY DEMENTIA DEMENTIA 

4)4) VASCULAR  VASCULAR PARKINSONISMPARKINSONISM

5)5) PUGILISTIC ENCEPHALOPATHY PUGILISTIC ENCEPHALOPATHY 

(TRAUMA)(TRAUMA)

Page 21: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 21/186

Examples of ParkinsonExamples of Parkinson--plus syndrome: plus syndrome:

6 )6 ) POSTPOST ENCEPHALOPATHY ENCEPHALOPATHY 

7) DRUG7) DRUG INDUCED E.G NEUROLEPTICS,INDUCED E.G NEUROLEPTICS,

PROCHLORPERAZINEPROCHLORPERAZINE AND ANDMETOCLOPRAMIDE.METOCLOPRAMIDE.

8) TOXIN8) TOXIN INDUCED E.G MANGANESE,INDUCED E.G MANGANESE, COPPER COPPER 

(( WILSON·S DISEASE) WILSON·S DISEASE)

Page 22: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 22/186

DIAGNOSISDIAGNOSIS

a)a)  The diagnosis of PD is based on the clinical symptoms & The diagnosis of PD is based on the clinical symptoms &signs.signs.

b)b) Blood & CSF examination and cerebral imaging such as CTBlood & CSF examination and cerebral imaging such as CT

Scan, MRI are non contributory in making the diagnosis of Scan, MRI are non contributory in making the diagnosis of 

PD.PD.

c)c) Positron Emission Tomography (PET) using fluorodopa hasPositron Emission Tomography (PET) using fluorodopa has

been useful in detecting loss of dopa uptake in the striatum . Itbeen useful in detecting loss of dopa uptake in the striatum . It

shows 60% reduction of fluorodopa uptake.shows 60% reduction of fluorodopa uptake.

d)d) Single Photon Emission Computerised TomographySingle Photon Emission Computerised Tomography

(SPECT).(SPECT).

Page 23: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 23/186

DIAGNOSISDIAGNOSIS

DN A  Analysis:DN A  Analysis: -- mitochondrial complex 1 activity ismitochondrial complex 1 activity isreduced, alterations in DN A, Monoamine oxidasereduced, alterations in DN A, Monoamine oxidase--BB(M AO(M AO--B) activity increased.B) activity increased.

 The diagnosis is usually made on the basis of history  The diagnosis is usually made on the basis of history & clinical examination. Handwriting samples,& clinical examination. Handwriting samples,speech analysis, interview questions that focus onspeech analysis, interview questions that focus on

developing symptomatology & physical examinationdeveloping symptomatology & physical examination

are used in the preclinical stage to detect early are used in the preclinical stage to detect early manifestations of the disease.manifestations of the disease.

 The diagnosis of PD can be made if at least two of  The diagnosis of PD can be made if at least two of 

the cardinal features are present.the cardinal features are present.

Page 24: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 24/186

DIAGNOSISDIAGNOSIS

g)g) EMG may be done to find out the level of rigidity & alsoEMG may be done to find out the level of rigidity & also

to know the increase in the reaction time & movementto know the increase in the reaction time & movement

time.time.

Page 25: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 25/186

 A TYPICAL EMG A TYPICAL EMG

Page 26: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 26/186

DIFFERENTIAL DIAGNOSISDIFFERENTIAL DIAGNOSIS

Page 27: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 27/186

PATHOPHYSIOLOGY PATHOPHYSIOLOGY 

Fig. 1: Coronal section of the brain, showing nigrostriatal pathways andlocation of selective dopaminergic degeneration in patients with

Parkinson's disease

Guttman, M. et al. CMAJ 2003;168:293-301

Page 28: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 28/186

PATHOPHYSIOLOGY PATHOPHYSIOLOGY 

InIn Parkinson·s disease, there is degeneration of Parkinson·s disease, there is degeneration of 

dopaminergic neurondopaminergic neuron in the substantialin the substantial NigraNigra

  par compacta associated with par compacta associated with lewylewy body;body;

causing decreased striatal dopamine (putamencausing decreased striatal dopamine (putamen

and caudate nucleus) level. This is thought toand caudate nucleus) level. This is thought to

be related tobe related to mitochondrialmitochondrial DNA dysfunction.DNA dysfunction.

Page 29: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 29/186

EPIDEMIOLOGY EPIDEMIOLOGY 

PREVALENCE:PREVALENCE:

 Worldwide Worldwide, based on the available prevalence, based on the available prevalence

studies, there are likely more than 6 Millionstudies, there are likely more than 6 Million

 people with PD. However, due to many people people with PD. However, due to many people

 with PD remaining undiagnosed, there may be with PD remaining undiagnosed, there may be

millions more. In China alone there are moremillions more. In China alone there are more

than 1.7Million people with PD.than 1.7Million people with PD.

Page 30: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 30/186

EPIDEMIOLOGY EPIDEMIOLOGY 

DecreasingDecreasing orderorder of of prevalence prevalence ::

 Amish Amish community>Brescia>Nebraska,>community>Brescia>Nebraska,> PersiaPersia

ByBy countrycountry per per 100100,,000000 of of population population

USA USA--329329--107107,, Japan Japan 193193--7676««NigeriaNigeria 6767««««KoreaKorea

1919,, EthiopiaEthiopia 77

PrevalencePrevalence of of PS/PDPS/PD isis risingrising slowlyslowly with with agingaging

 population population

Page 31: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 31/186

EPIDEMIOLOGY EPIDEMIOLOGY 

INCIDENCEINCIDENCE RATESRATES

Sweden 22.5Sweden 22.5--7.9>7.9>faroesfaroes Island>US A 20.3Island>US A 20.3--13.013.0

«««««««.England 12««««.. Libya 45.«««««««.England 12««««.. Libya 45.

 AGE AGE DISTRIBUTION:DISTRIBUTION:

InIn 1875, Henri1875, Henri HuchaudHuchaud(1844(1844--1911) detailed the first1911) detailed the first

case Juvenile Parkinson·s disease. He described a 3case Juvenile Parkinson·s disease. He described a 3

 year year old who had all the clinical features of PD.old who had all the clinical features of PD.

Page 32: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 32/186

EPIDEMIOLOGY EPIDEMIOLOGY 

 The The youngest reported case of PD. The youngest reported case of PD. The

 youngest reported case of PD since then is that youngest reported case of PD since then is that

of a 10 year old girl from Oklahoma whoof a 10 year old girl from Oklahoma who

showed her first symptoms of PD at only 2yearsshowed her first symptoms of PD at only 2years

old. However, it·s very uncommon for peopleold. However, it·s very uncommon for people

under the age of 30 to develop PD.under the age of 30 to develop PD.

Page 33: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 33/186

EPIDEMIOLOGY EPIDEMIOLOGY 

PDPD usually occurs when people are significantlyusually occurs when people are significantly

older than that and becomes increasingly moreolder than that and becomes increasingly more

common withcommon with age.age.

 The The average age at which symptoms usuallyaverage age at which symptoms usually

begin differs from country to country, with thebegin differs from country to country, with theoldest average onset being in Sweden 65.6 andoldest average onset being in Sweden 65.6 and

Estonia 66.9.Estonia 66.9.

Page 34: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 34/186

EPIDEMIOLOGY EPIDEMIOLOGY 

InIn Nigeria,Nigeria, meanmean ageage of of onsetonset forfor idiopathicidiopathic

PDPD was was 5555..66 years years (Osuntokun,(Osuntokun, 19791979))

RecentlyRecently,, meanmean ageage of  of onsetonset forfor PDPD inin

NigeriaNigeria was was discovereddiscovered toto bebe 6161..55 years years

(Okubadejo(Okubadejo etet alal..,, 20102010))

Page 35: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 35/186

EPIDEMIOLOGY EPIDEMIOLOGY 

 There There isis likelihoodlikelihood of of Parkinson·sParkinson·s diseasedisease

increasingincreasing sharplysharply atat thethe ageage of  of 6060,, andand peaks peaks inin

thosethose agedaged 8585--8989 years years oldold..

 The The likelihoodlikelihood of of developingdeveloping PDPD startsstarts toto declinedecline

atat 9090 years years of of ageage andand reducesreduces eveneven furtherfurther afterafter

thatthat PDPD isis very very rarerare amongstamongst thethe very very oldold--thosethose

 people people overover 100100 andand eveneven inin thosethose people people overover 110110

toto 119119 years years oldold..

Page 36: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 36/186

EPIDEMIOLOGY EPIDEMIOLOGY 

GENDER GENDER DISTRIBUTIONDISTRIBUTION

 The The ratioratio of of malesmales toto femalesfemales differsdiffers aa lotlot according according toto thethe

country country.. There There isis aa stark stark contrastcontrast betweenbetween aa clearclear MaleMale dominancedominance inin

NigeriaNigeria andand Japan Japan where where Women Women dominatedominate inin PDPD..

RATIORATIO OFOF MENMEN TO TO FEMALEFEMALE::

NigeriaNigeria 33..33,, Tanzania Tanzania 22..7272,, UU..SS.. A A 11..9191--11..00 ee..tt..cc

Page 37: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 37/186

EPIDEMIOLOGY EPIDEMIOLOGY 

RACIALRACIAL DIFEFRENCESDIFEFRENCES::

 The The risk risk of  of PDPD increasesincreases according according toto HairHair

colourcolour.. PeoplePeople with with Black Black hairhair were were foundfound toto bebe

leastleast proneprone toto PDPD..

PeoplePeople with with brownbrown hairhair areare 4040%% moremore likely likely totodevelopdevelop PDPD.. And, And, thosethose with with blondeblonde hairhair 6060%% moremore

likely likely toto developdevelop PDPD..

Page 38: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 38/186

EPIDEMIOLOGY EPIDEMIOLOGY 

 Worst Worst atat risk risk areare peoplepeople with with RedRed hairhair which which areare twicetwice atat

risk risk.. PDPD andand hairhair colourcolour shareshare somesome biochemistry biochemistry..

OCCUPATIONALOCCUPATIONAL DIFFERENCESDIFFERENCESPDPD isis farfar moremore commoncommon amongstamongst Welders Welders.. PrevalencePrevalence isis

significantly significantly higherhigher amongstamongst Physicians,Physicians, Dentist,Dentist, Teaches, Teaches,

Lawyers,Lawyers, Scientists,Scientists, andand ReligionReligion--relatedrelated jobsjobs..

Page 39: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 39/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

N A TUR  AL COURSE OF P ARKINSON·S DISE ASEN A TUR  AL COURSE OF P ARKINSON·S DISE ASE

RelativelyRelatively little is known about the natural course of little is known about the natural course of 

PD. Although always progressive, the natural course isPD. Although always progressive, the natural course is

 very variable. (Poewe, 1998). The first symptoms are very variable. (Poewe, 1998). The first symptoms are

usually unilateral. (Olanow, et al., 2001usually unilateral. (Olanow, et al., 2001).). Around three Around three

 years after the first symptoms present, it typically years after the first symptoms present, it typically

develops into a bilateral disorder, usually still withdevelops into a bilateral disorder, usually still with

intact balanceintact balance.. (Muller, et al., 2000)(Muller, et al., 2000)

Page 40: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 40/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

ProblemsProblems with balance develop about two to three with balance develop about two to three

 years later, although some patients reach this stage years later, although some patients reach this stage

only seventeen years after the start of the disease.only seventeen years after the start of the disease.

(Muller, et al., 2000) Recurrent falling starts on(Muller, et al., 2000) Recurrent falling starts on

average ten years after the first symptoms. (average ten years after the first symptoms. ( Wenning Wenning,,

et al., 1999) Eventually, nearly all patients will haveet al., 1999) Eventually, nearly all patients will have

impaired balance and will fall repeatedlyimpaired balance and will fall repeatedly..

Page 41: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 41/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

 This This formsforms aa threatthreat toto qualityquality of of lifelife.. (Schrag,(Schrag, etet alal..,,

20002000)) Initially,Initially, patients patients with with balancebalance problems problems cancan

standstand andand walk  walk onon theirtheir own,own, butbut onon averageaverage afterafter

eighteight years, years, fallingfalling becomes,becomes, inin combinationcombination with with thethe

otherother symptoms,symptoms, aa moremore severesevere problem problem.. EventuallyEventually

thethe balancebalance impairmentimpairment cancan becomebecome soso severesevere thatthat thethe

 patient patient isis permanently permanently confinedconfined toto aa wheelchair wheelchair oror

bed,bed, if if hehe hashas nono helphelp of of othersothers..

Page 42: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 42/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

LessLess than five percent of patients with PD arethan five percent of patients with PD are

confined to a wheelchair or bed eventually (Globalconfined to a wheelchair or bed eventually (Global

Parkinson Disease Survey Steering Committee, 2002).Parkinson Disease Survey Steering Committee, 2002).

In later stages non motor symptoms may arise, suchIn later stages non motor symptoms may arise, such

as dementia. In geriatric patients PD is oftenas dementia. In geriatric patients PD is often

accompanied by depression.accompanied by depression.

Page 43: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 43/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

1)1)  TREMORS: TREMORS:

(a)(a) It consists of regular , rhythmic , alternate contractionIt consists of regular , rhythmic , alternate contraction

antagonist & agonist muscles @ 4antagonist & agonist muscles @ 4--6 times / second.6 times / second.

(b)(b)  The tremors occurs due to uninhibited activity of the basal The tremors occurs due to uninhibited activity of the basal

gangliaganglia--corticocortico--thalamus circuit as a result of degeneration of thalamus circuit as a result of degeneration of 

the striatonigral pathway.the striatonigral pathway.

(c)(c) It is a rhythmic involuntary movement normally affectingIt is a rhythmic involuntary movement normally affecting

the limbs.the limbs.

Page 44: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 44/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

d)d) It is the 1It is the 1stst complain of the patient but in some patientcomplain of the patient but in some patient

Bradykinesia is usually the first recognized symptom.Bradykinesia is usually the first recognized symptom.

e)e) Resting tremor present mainly PIN / PILL rolling type as likeResting tremor present mainly PIN / PILL rolling type as like

 pin / pill rolls between the thumb & index finger. pin / pill rolls between the thumb & index finger.

f)f) Frequency is 4Frequency is 4--6 times / second in early stage & 66 times / second in early stage & 6--8 times/8 times/

second in later stage.second in later stage.

g)g) Maximal at periphery & affects the arm more frequentlyMaximal at periphery & affects the arm more frequently

than the leg.than the leg.

Page 45: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 45/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASEh)h)  Tremor is increased by stress & disappeared during sleep & Tremor is increased by stress & disappeared during sleep &

goal directed movements.goal directed movements.

i)i)  The hand which is most affected assumes a posture of flexion The hand which is most affected assumes a posture of flexion

of the MCP joints with extension of the more distal joints.of the MCP joints with extension of the more distal joints.

2) RIGIDITY 2) RIGIDITY 

a)a) Rigidity is defined as resistance to passive motion that is notRigidity is defined as resistance to passive motion that is not

 velocity dependent. velocity dependent.

Page 46: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 46/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

b)b) It is manifested as co contraction of agonist & antagonistIt is manifested as co contraction of agonist & antagonist

muscles due to an increase in the supraspinal influences onmuscles due to an increase in the supraspinal influences on

the normal spinal system causing increase tone in the agonistthe normal spinal system causing increase tone in the agonist

& the antagonist.There is an increased discharge of gamma& the antagonist.There is an increased discharge of gamma

motor neuronsmotor neurons..

c)c)  The patient usually complains of rigidity as a sensation of  The patient usually complains of rigidity as a sensation of 

heaviness or stiffness of the limbsheaviness or stiffness of the limbs..

d)d) Present in almost all cases of PDPresent in almost all cases of PD

Page 47: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 47/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

e)e) Cog wheel type rigidity is present. There is intermittentCog wheel type rigidity is present. There is intermittent

resistance throughout ROM.resistance throughout ROM.

Lead pipe rigidity is also seen in some cases. There isLead pipe rigidity is also seen in some cases. There is

constant resistance throughout ROM.constant resistance throughout ROM.

f)f) It affects proximal muscles first, mainly shoulders & neck andIt affects proximal muscles first, mainly shoulders & neck and

then progress to face & extremities and then the whole body.then progress to face & extremities and then the whole body.

g)g)  As the disease progresses ; Rigidity becomes more severe As the disease progresses ; Rigidity becomes more severe..

h)h) Mental concentration & Emotional tension may increase theMental concentration & Emotional tension may increase the

amount of rigidity presentamount of rigidity present..

Page 48: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 48/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

i)i) Rigidity decreases the ability of patients to move easily. ForRigidity decreases the ability of patients to move easily. For

e.g.; loss of bed mobility , loss of reciprocal arm swing duringe.g.; loss of bed mobility , loss of reciprocal arm swing during

gaitgait..

j)j) Prolonged rigidity results in decreased available ROM &Prolonged rigidity results in decreased available ROM &

serious secondary complications of contracture & posturalserious secondary complications of contracture & postural

deformity.deformity.

k)k) Rigidity also has a direct impact on increasing RestingRigidity also has a direct impact on increasing Resting

Energy Expenditure (REE) & fatigue levelsEnergy Expenditure (REE) & fatigue levels..

Page 49: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 49/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

3) BRADYKINESIA 3) BRADYKINESIA 

a)a) Bradykinesia refers to slowness & difficulty in maintainingBradykinesia refers to slowness & difficulty in maintaining

movements. It is theoretically presumed that it could bemovements. It is theoretically presumed that it could bebecause of difficulty to the basal ganglia to integrate sensorybecause of difficulty to the basal ganglia to integrate sensory

information.information.

b)b) Movements are typically reduced in speed, range & amplitudeMovements are typically reduced in speed, range & amplitude; termed hypokinesia.; termed hypokinesia.

Page 50: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 50/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

c)c) Patient with PD typically demonstrate micrographia ; anPatient with PD typically demonstrate micrographia ; an

abnormally small hand writing that is difficult to read.abnormally small hand writing that is difficult to read.

d)d) Patient feels difficulties in ADL such as bathing, dressing,Patient feels difficulties in ADL such as bathing, dressing,

rising from a chair, turning over in bed, loss of dexterity &rising from a chair, turning over in bed, loss of dexterity &

making buttoning etc.making buttoning etc.

e)e) Patient experiences difficulty in integrating two motorPatient experiences difficulty in integrating two motor

 programmes at the same time.(dual tasking) programmes at the same time.(dual tasking)

f)f) Patient feels hesitation on initiation of movements & earlyPatient feels hesitation on initiation of movements & early

fatigue.fatigue.

Page 51: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 51/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

4) POSTURAL INSTABILITY 4) POSTURAL INSTABILITY 

a)a) Simians posture or Stooped postureSimians posture or Stooped posture..

b)b) Head protruded forward , flexion at neck , trunk , elbow , hipHead protruded forward , flexion at neck , trunk , elbow , hip

& knee.& knee.

c)c)  Tandem stance : Tandem stance :-- walking on a single line with narrow BOS. walking on a single line with narrow BOS.

d)d) Balance is poor & patient fall if encounters even minorBalance is poor & patient fall if encounters even minor

 postural perturbation ( a slight push ) due to loss of postural postural perturbation ( a slight push ) due to loss of postural

reflexes.reflexes.

Page 52: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 52/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

5) GAIT5) GAIT

a)a) Parkinsonian gait / Freezing / Festinating / Shuffling / ToeParkinsonian gait / Freezing / Festinating / Shuffling / Toe

 ²  ²heel / Hurrying gait.heel / Hurrying gait.

b)b) Patient takes small steps on walkingPatient takes small steps on walking..

c)c) Patient feels difficulty in initiating movement & to stopPatient feels difficulty in initiating movement & to stop

 walking once started. walking once started.

d)d)  There is loss of normal heel toe progression. The toe strikes There is loss of normal heel toe progression. The toe strikes

first.first.

e)e) Loss of arm swing & pelvic rotation.Loss of arm swing & pelvic rotation.

Page 53: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 53/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASEf)f)  The forward leaning of the trunk moves the body·s COG forward The forward leaning of the trunk moves the body·s COG forward

thus causing the patient to hasten his/her pace in order to catchthus causing the patient to hasten his/her pace in order to catch

up COG.up COG.

g)g) Stride length decreases & speed increased therefore called asStride length decreases & speed increased therefore called as

festinating gait.festinating gait.

h)h) Stance phase & double support time are lengthened while theStance phase & double support time are lengthened while the

 period of single limb support is shortened. period of single limb support is shortened.

i)i)  Turning or changing direction is particularly difficult. Turning or changing direction is particularly difficult.

j)j) Patient are able to stop only when they come in contact with anPatient are able to stop only when they come in contact with an

ob ect or a wall.ob ect or a wall.

Page 54: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 54/186

CLINICALCLINICAL PRESENTATION OFPRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

INDIRECT IMPAIREMENTS & COMPLICATIONSINDIRECT IMPAIREMENTS & COMPLICATIONS

1) MASKED FACE1) MASKED FACE

a)a) Lack of facial expression.Lack of facial expression.

b)b) Subsequent loss of blinkingSubsequent loss of blinking..

c)c) Smiling may be possible only on command or volitional effort.Smiling may be possible only on command or volitional effort.

d)d)  This can have a significant impact on social interaction & This can have a significant impact on social interaction &

social disability.social disability.

Page 55: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 55/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

2) POVERTY OF MOVEMENT2) POVERTY OF MOVEMENT

a)a) Rotational movement are reduced, resulting in movementsRotational movement are reduced, resulting in movements

that are basically uniplanar (in one plane of motion ) e.g.;that are basically uniplanar (in one plane of motion ) e.g.;

flexionflexion²  ²extension in sagital plane.extension in sagital plane.

b)b)  There is an overall decrease in total number of  There is an overall decrease in total number of 

movementsmovements..c)c) Movement impoverishment can lead to mental fatigue &Movement impoverishment can lead to mental fatigue &

loss of motivation.loss of motivation.

Page 56: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 56/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

3) FATIGUE3) FATIGUE

a)a) In a patient of PD fatigue is one of the symptom.In a patient of PD fatigue is one of the symptom.

b)b)  The patient has difficulty in sustaining activity & experiences The patient has difficulty in sustaining activity & experiencesincreasing weakness.increasing weakness.

c)c) Repetitive motor acts may start out strong but decrease inRepetitive motor acts may start out strong but decrease in

strength as the activity progresses.strength as the activity progresses.

d)d)  The 1 The 1stst few words spoken may be loud & strong but diminishfew words spoken may be loud & strong but diminish

rapidly as speech progresses.(palilalia)rapidly as speech progresses.(palilalia)

Page 57: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 57/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

4) MUSCULOSKELETAL CHANGES4) MUSCULOSKELETAL CHANGES

a)a) Patient shows the effects of generalized musculoskeletalPatient shows the effects of generalized musculoskeletal

deconditioning.deconditioning.

b)b)  The more chronic & generalized the disease becomes , the The more chronic & generalized the disease becomes , the

greater the level of muscle weakness & fatigue.greater the level of muscle weakness & fatigue.

c)c) Loss of flexibility.Loss of flexibility.

d)d) Lack of movement in any body segment leads to contractureLack of movement in any body segment leads to contracture

development of both contractile & nondevelopment of both contractile & non --contractile tissue.contractile tissue.

Page 58: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 58/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

e)e) Contractures mainly develops in hip & knee flexors, hipContractures mainly develops in hip & knee flexors, hip

rotators & adductors, plantar flexors, dorsal spine & neck rotators & adductors, plantar flexors, dorsal spine & neck 

flexors, shoulders adductors & internal rotators, and elbow flexors, shoulders adductors & internal rotators, and elbow 

flexors.flexors.

f)f) Kyphosis is the most common postural deformity.Kyphosis is the most common postural deformity.

g)g) Some pt. may develop Scoliosis from leaning consistently toSome pt. may develop Scoliosis from leaning consistently toone side when sitting or walking.one side when sitting or walking.

h)h) Scoliosis generally results from unequal distribution of rigidityScoliosis generally results from unequal distribution of rigidity

in the trunk.in the trunk.

Page 59: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 59/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

i)i) Older patient with reduced activity levels & poor diet are likelyOlder patient with reduced activity levels & poor diet are likely

to develop osteoporosis.to develop osteoporosis.

5) S W ALLO WING DYSFUNCTION5) S W ALLO WING DYSFUNCTIONa)a) Dysphagia ,impaired swallowing, is present in 50Dysphagia ,impaired swallowing, is present in 50--90 % of pt.90 % of pt.

b)b) Dysphagia can lead to choking or aspirationDysphagia can lead to choking or aspiration pnuemonia pnuemonia &&

impaired nutrition.impaired nutrition.

c)c) Dysphagia is the result of Dysphagia is the result of rigidity,reducedrigidity,reduced mobility& restrictedmobility& restricted

range of movement.range of movement.

Page 60: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 60/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

d)d) Patient experiences problems in all four stages of swallowing;Patient experiences problems in all four stages of swallowing;

oral preparatory, oral, pharyngeal & esophagealoral preparatory, oral, pharyngeal & esophageal..

e)e) Patient typically experiences excessive drooling (sialorrhea) asPatient typically experiences excessive drooling (sialorrhea) as

a result of increased salivary production & decreaseda result of increased salivary production & decreased

spontaneous swallowing.spontaneous swallowing.

6) COMMUNICATION DYSFUNCTION6) COMMUNICATION DYSFUNCTION

a)a) Speech is impaired in 50Speech is impaired in 50-- 73 % of patient.73 % of patient.

b)b) Speech difficulties are also result of rigidity & bradykinesiaSpeech difficulties are also result of rigidity & bradykinesia..

Page 61: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 61/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

c)c) Hypokinetic Dysarthria; which is characterised by decreasedHypokinetic Dysarthria; which is characterised by decreased

 volume , monotone or volume , monotone or monopitchmonopitch speech, imprecise orspeech, imprecise or

distorted disarticulation & uncontrolled speech rate.distorted disarticulation & uncontrolled speech rate.

d)d) Patients experiences reduced mobility , restricted range of Patients experiences reduced mobility , restricted range of 

movement& uncontrolled rate of movement of musclesmovement& uncontrolled rate of movement of muscles

controlling respiration , phonation , resonation & articulation.controlling respiration , phonation , resonation & articulation.

7) VISUAL & SENSORIMOTOR DISTURBANCES7) VISUAL & SENSORIMOTOR DISTURBANCES

a)a) Conjugate gaze & saccadic eye movements may also beConjugate gaze & saccadic eye movements may also be

impairedimpaired..

Page 62: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 62/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

b)b)  Visual disturbances are common in PD. These can include Visual disturbances are common in PD. These can include

blurring of vision & difficulty in reading which can not beblurring of vision & difficulty in reading which can not be

corrected by glasses.corrected by glasses.c)c) Eye movements may have a jerky & cog wheeling quality.Eye movements may have a jerky & cog wheeling quality.

d)d) Pupillary abnormalities are also possible with decreased reflexPupillary abnormalities are also possible with decreased reflex

responses to light & nociceptive stimuli.responses to light & nociceptive stimuli.

e)e)  Akathisia; it is often described as painful and interferes with Akathisia; it is often described as painful and interferes with

relaxation & sleeprelaxation & sleep..

Page 63: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 63/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

f)f) 50% patient experiences50% patient experiences paresthesias paresthesias & pain. This can include& pain. This can include

sensations of numbness ,tingling, abnormal temperature &sensations of numbness ,tingling, abnormal temperature &

 pain that is cramp pain that is cramp--like & poorly localizedlike & poorly localized..

g)g) Postural stress syndromePostural stress syndrome..

88) COGNITIVE DYSFUNCTION) COGNITIVE DYSFUNCTIONa)a) Dementia occurs in approximately 1/3Dementia occurs in approximately 1/3rdrd of the patients withof the patients with

PD.PD.

Page 64: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 64/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

b)b) BradyphreniaBradyphrenia, a disorder of intellectual function, is common in, a disorder of intellectual function, is common in

 pt. It is characterised by a slowing of thought processes with pt. It is characterised by a slowing of thought processes with

lack of concentration & attentionlack of concentration & attention..c)c) Patient May also demonstrate learning deficits.Patient May also demonstrate learning deficits.

d)d) Perceptual deficits also present.Perceptual deficits also present.

e)e) Deficits have been reported in vertical perception, topographicDeficits have been reported in vertical perception, topographic

orientation, body scheme and spatial relations.orientation, body scheme and spatial relations.

Page 65: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 65/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

9) BEHAVIOURAL DYSFUNCTION9) BEHAVIOURAL DYSFUNCTION

a)a) Depression is the most common, occurring in25Depression is the most common, occurring in25--40% of patient.40% of patient.

b)b) Patient may demonstrate symptoms of major depressionPatient may demonstrate symptoms of major depression,including apathy, passivity, loss of ambition or enthusiasm &,including apathy, passivity, loss of ambition or enthusiasm &

changes in appetite, sleep and dependency. Suicidal thoughtschanges in appetite, sleep and dependency. Suicidal thoughts

may be presentmay be present..

c)c) Dysrhythmic disorder characterised by variability in dysphoricDysrhythmic disorder characterised by variability in dysphoric

mood, or typical depression characterised by intermittentmood, or typical depression characterised by intermittent

episodes of severe anxiety.episodes of severe anxiety.

Page 66: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 66/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

d)d) Drug related psychoses can occur.Drug related psychoses can occur.

10) AUTONOMIC DYSFUNCTION10) AUTONOMIC DYSFUNCTION

a)a) DysautonomiaDysautonomia ; autonomic nervous system dysfunction occurs; autonomic nervous system dysfunction occursin patient.in patient.

b)b) Commons problems includes excessiveCommons problems includes excessive perspiration,greasy perspiration,greasy

skin,increasedskin,increased salivation,thermoregulatorysalivation,thermoregulatory

abnormalities(including uncomfortable sensation of heat orabnormalities(including uncomfortable sensation of heat or

cold)cold)..

Page 67: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 67/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

c)c) Bladder dysfunction includes urinary frequency, urgency &Bladder dysfunction includes urinary frequency, urgency &

nocturia.nocturia.

d)d) Sexual dysfunction includes impotence.Sexual dysfunction includes impotence.

e)e) Patient have low appetites & decreased motility of the GIT.Patient have low appetites & decreased motility of the GIT.

f)f) Constipation is also problem seen in patient.Constipation is also problem seen in patient.

11) CARDIOPULMONARY DYSFUNCTION11) CARDIOPULMONARY DYSFUNCTION

a)a) Pulmonary function impairment is reported in 84% of patientsPulmonary function impairment is reported in 84% of patients..

b)b)  Airway obstruction leads to pulmonary failure. Airway obstruction leads to pulmonary failure.

Page 68: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 68/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

c)c) Orthostatic hypotension & low resting blood pressure. CardiacOrthostatic hypotension & low resting blood pressure. Cardiac

arrhythmias can also occurs as a result of Larrhythmias can also occurs as a result of L--DopaDopa ..

d)d) Bradykinetic disorganization of respiratory movements.Bradykinetic disorganization of respiratory movements.

e)e) Restrictive dysfunction due to decreased chest expansion thatRestrictive dysfunction due to decreased chest expansion that

occurs as a result of rigidity of trunk muscles, loss of occurs as a result of rigidity of trunk muscles, loss of 

musculoskeletal flexibility & kyphotic posture.musculoskeletal flexibility & kyphotic posture.

f)f) Decrease in FVC , FEV1 & increase in RV , RA  W (airwayDecrease in FVC , FEV1 & increase in RV , RA  W (airway

resistance).resistance).

Page 69: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 69/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

g)g) In long standing disease, the lower extremities may exhibitIn long standing disease, the lower extremities may exhibit

circulatory changes owing to venous pooling as a result of circulatory changes owing to venous pooling as a result of 

decreased mobility & prolonged sitting. Thus pt. can presentdecreased mobility & prolonged sitting. Thus pt. can present

 with mild to moderate edema of the feet & ankles, which with mild to moderate edema of the feet & ankles, which

usually subsides during sleep.usually subsides during sleep.

12) SKIN INFECTIONS12) SKIN INFECTIONS

a)a) Dermatitis can occur due to increased secretion by sweat &Dermatitis can occur due to increased secretion by sweat &

sebaceous glands.sebaceous glands.

Page 70: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 70/186

CLINICAL PRESENTATION OFCLINICAL PRESENTATION OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

13) GLABELLAR TAP SIGN13) GLABELLAR TAP SIGN

a)a)  Tapping forehead causes repetitive blinking. Tapping forehead causes repetitive blinking.

14) OLFACTORY DYSFUNCTION14) OLFACTORY DYSFUNCTIONa)a) It is present in 75It is present in 75 ²  ² 90 % of patient.90 % of patient.

Page 71: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 71/186

PROGNOSTIC FACTOR OF PARKINSON·SPROGNOSTIC FACTOR OF PARKINSON·S

DISEASEDISEASE

 According to KNGF guideline development group of  According to KNGF guideline development group of 

Parkinson's disease 2004, physical therapy influences physicalParkinson's disease 2004, physical therapy influences physical

inability and falling as prognostic in Parkinson·s disease.inability and falling as prognostic in Parkinson·s disease.

 Jankovic et al., distinguish Jankovic et al., distinguish TREMOR DOMINANT TYPE TREMOR DOMINANT TYPE of of 

Parkinson's disease andParkinson's disease and AKINETIC RIGID TYPE AKINETIC RIGID TYPE

  TREMOR DOMINANT TYPE AKINETIC RIGID TYPE

1 ) Tremor is the initial symptom. Rigidity and hypokinesia are the initialsymptoms.

2 ) Process often develop more slowly. More rapid course of Parkinson·s disease in

motor and cognitive areas.

3) Characterized by problems of balance gate

and freezing.

Characterize by less frequent dominant and

cognition impairment.

Page 72: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 72/186

PROGNOSTIC FACTOR OF PARKINSON·SPROGNOSTIC FACTOR OF PARKINSON·S

DISEASEDISEASE

In patients of young age cognition functions and posturalIn patients of young age cognition functions and postural

reflexes often remain unimpaired.reflexes often remain unimpaired.

Patients with recurrent falls and with insufficient physicalPatients with recurrent falls and with insufficient physical

activity has an unfavourable prognosisactivity has an unfavourable prognosis..

PD is a progressive disorder but its rate of progression isPD is a progressive disorder but its rate of progression is

variable.variable.

Before LBefore L--dopa therapy 28% of pt. became severely disabled ordopa therapy 28% of pt. became severely disabled or

died with in 5 yrs of diagnosis , 61% with in 10 yrs & 83%died with in 5 yrs of diagnosis , 61% with in 10 yrs & 83%

with in 15 yrswith in 15 yrs..

PROGNOSTIC FACTOR OFPROGNOSTIC FACTOR OF

Page 73: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 73/186

PROGNOSTIC FACTOR OFPROGNOSTIC FACTOR OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Following LFollowing L--dopa therapy only 9% becamedopa therapy only 9% became

disabled or had died at 5 yrs , 21% at 10 yrs &disabled or had died at 5 yrs , 21% at 10 yrs &

37.5% at 15 yrs.37.5% at 15 yrs.

Death may occur from aspiration pneumoniaDeath may occur from aspiration pneumonia

,septicemia from UTI, decubitus ulcer or from,septicemia from UTI, decubitus ulcer or from

secondary causes like vascular disease orsecondary causes like vascular disease or

neoplasia.neoplasia.

Page 74: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 74/186

MANAGEMENT OF PARKINSON·SMANAGEMENT OF PARKINSON·S

DISEASEDISEASE

 The The managementmanagement of of PDPD followsfollows thethe multidisciplinarymultidisciplinary approachapproach..

 This This involveinvolve thethe MULTIDISCIPLINARY MULTIDISCIPLINARY TEAM TEAM thatthat includesincludes::

NeurologistNeurologist

 A rehabilitation Physician A rehabilitation Physician

 A physical therapist A physical therapist

 An occupational therapist An occupational therapist

 A speech therapist A speech therapist

 A neuropsychologist A neuropsychologist

 A recreational activities supervisor A recreational activities supervisor

 A social work  A social work 

 A PD specialist Nurse A PD specialist Nurse

TT

Page 75: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 75/186

MANAGEMENT OF PARKINSON·S DISEASEMANAGEMENT OF PARKINSON·S DISEASE

MEDICAL THERAPY MEDICAL THERAPY 

Page 76: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 76/186

MEDICAL THERAPY MEDICAL THERAPY 

Page 77: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 77/186

MEDICAL THERAPY MEDICAL THERAPY 

Page 78: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 78/186

MEDICAL THERAPY MEDICAL THERAPY 

Page 79: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 79/186

MANAGEMENT OF PARKINSON·SMANAGEMENT OF PARKINSON·S

DISEASEDISEASE

MEDICAL THERAPY MEDICAL THERAPY 

 Treatment algorithm for the Treatment algorithm for the

management of the earlymanagement of the earlystages of Parkinson·sstages of Parkinson·s

disease. As shown below disease. As shown below 

Page 80: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 80/186

Page 81: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 81/186

MANAGEMENT OF PARKINSON·SMANAGEMENT OF PARKINSON·S

DISEASEDISEASE

SURGICAL THERAPY SURGICAL THERAPY 

 A. A. Stereotactic surgery is done on the basal ganglia by ruling outStereotactic surgery is done on the basal ganglia by ruling out

 part of the region ( part of the region (--tomy) as in:tomy) as in:

Pallidotomy: clearing of destructive lesion in globus pallidusPallidotomy: clearing of destructive lesion in globus pallidus

internus, decrease dyskinesia.internus, decrease dyskinesia.

 Thalamotomy: Clearing of destructive lesion in the ventral Thalamotomy: Clearing of destructive lesion in the ventralintermedius nucleus of the thalamus, decreases tremor.intermedius nucleus of the thalamus, decreases tremor.

Stereotactic surgery started in 1950 before LevoStereotactic surgery started in 1950 before Levo--dopa not in use.dopa not in use.

Page 82: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 82/186

SURGICAL THERAPY SURGICAL THERAPY 

B.B. Deep Brains Stimulator(DBS) : started in 1997, stimulationDeep Brains Stimulator(DBS) : started in 1997, stimulation

takes place by implantation of electrode in the brain,takes place by implantation of electrode in the brain,

specifically in ventral intermedius nucleus of the thalamus to aspecifically in ventral intermedius nucleus of the thalamus to a

 pacemaker. pacemaker.

Complications might occur as a consequence:Complications might occur as a consequence:

By intervention itself(by damaging the surrounding tissue)By intervention itself(by damaging the surrounding tissue)

 The applied equipment( e.g. infection) The applied equipment( e.g. infection)

 The lesion or stimulation (among others falling problems The lesion or stimulation (among others falling problems

 paraesthesia and headache). paraesthesia and headache).

Page 83: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 83/186

SURGICAL THERAPY SURGICAL THERAPY 

C.C.  Transplantation technique: grafting of foetal cells, auto Transplantation technique: grafting of foetal cells, auto

transplantation with patient·s own adrenal medullary cells.transplantation with patient·s own adrenal medullary cells.

Page 84: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 84/186

MOTOR FEATURES OF PDMOTOR FEATURES OF PD

Initiation problemsInitiation problems

movements under scaledmovements under scaled motor instabilitymotor instability

slowingslowing

deterioration with simultaneous tasksdeterioration with simultaneous tasks  Tremor Tremor

NONNON MOTOR FEATURES OFMOTOR FEATURES OF

Page 85: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 85/186

NONNON--MOTOR FEATURES OFMOTOR FEATURES OF

PDPD Sleep:Sleep:

BowelsBowels

BladderBladder

PainPain

Postural hypotension *Postural hypotension *

Sexual dysfunctionSexual dysfunction

Sweating Sweating 

MANAGEMENT OFMANAGEMENT OF

Page 86: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 86/186

MANAGEMENT OFMANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

PHYSIOTHERAPY PHYSIOTHERAPY 

Physiotherapy intervention is broadly dividedPhysiotherapy intervention is broadly divided

into two processes:into two processes:

Diagnostic processDiagnostic process

 Therapeutic process (KNGF, 2004) Therapeutic process (KNGF, 2004)

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 87: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 87/186

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

DIAGNOSTIC PROCESSDIAGNOSTIC PROCESS

 This involves ASSESSMENTS and CLINICAL IMPRESSION. This involves ASSESSMENTS and CLINICAL IMPRESSION.

Subjective AssessmentSubjective Assessment

Objective AssessmentObjective Assessment

 Analysis of finding Analysis of finding

Plan of treatmentPlan of treatment

Goals of treatmentGoals of treatment

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 88: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 88/186

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

 Therapeutic process Therapeutic process

 This involves: This involves:

Means of treatmentMeans of treatment

Evaluation and follow upEvaluation and follow up

ReportingReporting

 The objectives or aims of physiotherapy are based on the The objectives or aims of physiotherapy are based on the

outcome from these two processes.outcome from these two processes.

For a patient with PD, the major objectives of physiotherapy are:For a patient with PD, the major objectives of physiotherapy are:

 To improve the quality of life To improve the quality of life

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 89: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 89/186

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

 To maintain the patient·s independence, safety, and well being. To maintain the patient·s independence, safety, and well being.

 To improve functional activity. To improve functional activity.

 To reduce or delay limitation in activities (disability). To reduce or delay limitation in activities (disability).

 ASSESSMENT ASSESSMENT

REFERRALREFERRAL

Early referral (immediately after diagnosis) to a physicalEarly referral (immediately after diagnosis) to a physicaltherapist is recommended to prevent or decrease complicationtherapist is recommended to prevent or decrease complication

as a result of falls and inactivity. (Plant et al., 2000; Morris,as a result of falls and inactivity. (Plant et al., 2000; Morris,

2000;2000; ChessonChesson, 1998 ), 1998 )

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 90: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 90/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

HenvelHenvel et al., stated the following information needed from theet al., stated the following information needed from the

referring physician:referring physician:

Name, date of birth and address of the patient.Name, date of birth and address of the patient.

Date of referralDate of referral

DiagnosisDiagnosis

Is other forms of parkinsonism excluded?Is other forms of parkinsonism excluded?

CoCo--morbiditymorbidity

Course of the health problemCourse of the health problem

Reason for referralReason for referral

Name, address and signature of the physicName, address and signature of the physic

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 91: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 91/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

HISTORY TAKINGHISTORY TAKING

 To get an accurate picture of the patient problem. To get an accurate picture of the patient problem.

Patient specific complaints questionnaire; for performance of Patient specific complaints questionnaire; for performance of 

activities and assessment of the treatment goal .it determinesactivities and assessment of the treatment goal .it determines

the functional status of individual patient.the functional status of individual patient.

history of falling questionnairehistory of falling questionnaire

freezing of gait questionnaire (FOG): This is used for patientfreezing of gait questionnaire (FOG): This is used for patient who have recently experienced that their feet seemed glued or who have recently experienced that their feet seemed glued or

stocked to the ground.stocked to the ground.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 92: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 92/186

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE For inventory of evaluation of falling or near fallingFor inventory of evaluation of falling or near falling

fall efficacy scalefall efficacy scale

fall diaryfall diary

LASA physical activity questionnaire; measure physicalLASA physical activity questionnaire; measure physical

activity of the elderly.activity of the elderly.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 93: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 93/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

 Analysis to formulate the objective to be tested: Analysis to formulate the objective to be tested:

Based on the information obtained while taking the medicalBased on the information obtained while taking the medical

history, a number of problems is formulated, these are to behistory, a number of problems is formulated, these are to be

tested in physical examination.tested in physical examination.

Possible objective are:Possible objective are:

1.1. Physical capacityPhysical capacity

2.2.  Transfer Transfer

3.3. Reaching and graspingReaching and grasping

4.4. Balance and gaitBalance and gait

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 94: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 94/186

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Physical ExaminationPhysical ExaminationPhysical therapist should determine if the patient is in ON OR Physical therapist should determine if the patient is in ON OR 

OFF period. For structured physical examination.OFF period. For structured physical examination.

¶QUICK REFERENCE CARD· CAN BE USE.¶QUICK REFERENCE CARD· CAN BE USE.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 95: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 95/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 96: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 96/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

Page 97: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 97/186

DISEASEDISEASE

NEUROLOGICAL ASSESSMENTNEUROLOGICAL ASSESSMENT

(1)(1) COGNITION :COGNITION :-- memory function , conceptual reasoning ,memory function , conceptual reasoning ,

 problem solving ability , attention and concentration are problem solving ability , attention and concentration are

reduced.reduced.

 Assessment instrument Assessment instrument ²  ² Mini Mental Status Exam (MMSE).Mini Mental Status Exam (MMSE).

2)2)  AFFECTIVE & PSYCHOSOCIAL FUNCTIONING : AFFECTIVE & PSYCHOSOCIAL FUNCTIONING :--

stress, anxiety , sadness , apathy , passivity , insomnia ,stress, anxiety , sadness , apathy , passivity , insomnia ,

aprexiaaprexia , wt. loss , inactivity , suicidal thoughts may present., wt. loss , inactivity , suicidal thoughts may present.

 Assessment instrument Assessment instrument ²  ² Geriatric Depressions ScaleGeriatric Depressions Scale

Beck Depression Inventory.Beck Depression Inventory.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 98: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 98/186

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

(3) VISUAL FUNCTION:(3) VISUAL FUNCTION:--

 Visual acuity, peripheral vision, accommodation, light & dark  Visual acuity, peripheral vision, accommodation, light & dark 

adaptation are reduced.adaptation are reduced.

Depth perception, blurring of vision, cataract, glaucoma, mayDepth perception, blurring of vision, cataract, glaucoma, may

 present. present.

Senile macular degeneration, diabetic retinopathy,Senile macular degeneration, diabetic retinopathy,

homonymoushomonymous hemianopiahemianopia may present.may present.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 99: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 99/186

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

(4) DYSPHAGIA & SPEECH IMPAIREMENT:(4) DYSPHAGIA & SPEECH IMPAIREMENT:--

Dysphagia , sialorrhea ( drooling) present.Dysphagia , sialorrhea ( drooling) present.

Hypokinetic dysarthria .Hypokinetic dysarthria .

Mutism.Mutism.

 Assessment instruments: The verbal learning test. Assessment instruments: The verbal learning test.

 The verbal comprehension test. The verbal comprehension test.

(5) MUSCLE PERFORMANCE:(5) MUSCLE PERFORMANCE:--

SpasticitySpasticity

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 100: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 100/186

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Strength reduced.Strength reduced.

Endurance decreased.Endurance decreased.

 Assessment Instrument: Manual Muscle grading Assessment Instrument: Manual Muscle grading

Modified Ashworth scale.Modified Ashworth scale.

Isokinetic Dynamometers.Isokinetic Dynamometers.

Hand Held Dynamometers.Hand Held Dynamometers.

(6) RIGIDITY:(6) RIGIDITY: --

Present in trunk, neck, extremities & face.Present in trunk, neck, extremities & face.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 101: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 101/186

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

(7) BRADYKINESIA:(7) BRADYKINESIA: --

Slowness of movement.Slowness of movement.

Increased Reaction Time (RT).Increased Reaction Time (RT).

Increased Movement Time (MT).Increased Movement Time (MT).

 Assessment instrument : Timed test for Rapid Alternating Assessment instrument : Timed test for Rapid Alternating

Movement (RAM).Movement (RAM).EMG for RT & MT.EMG for RT & MT.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 102: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 102/186

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

(8) JOINT RANGE OF MOTION:(8) JOINT RANGE OF MOTION: --

 AROM & PROM both decreased. AROM & PROM both decreased.

Loss of hip & knee extension, shoulder flexion, elbow Loss of hip & knee extension, shoulder flexion, elbow 

extension, dorsal spine & neck extension and axial rotation of extension, dorsal spine & neck extension and axial rotation of 

spine.spine.

 Assessment instrument: Assessment instrument: GoniometerGoniometer

(9) TREMORS :(9) TREMORS :--

Resting tremors.Resting tremors.

Mainly in periphery of upper limbs.Mainly in periphery of upper limbs.

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

Page 103: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 103/186

DISEASEDISEASE

(10) SENSORY INTEGRITY:(10) SENSORY INTEGRITY: --

Blunting of touch sensations.Blunting of touch sensations.

Loss of propioception more in lower extremities than upper,Loss of propioception more in lower extremities than upper,

distal than proximaldistal than proximal ParesthesiasParesthesias (sensation of numbness or tingling).(sensation of numbness or tingling).

(11) PAIN:(11) PAIN: --

Mild aching & cramp like.Mild aching & cramp like.

Poorly localized.Poorly localized.

Postural stress syndrome.Postural stress syndrome.

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

Page 104: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 104/186

DISEASEDISEASE Assessment Instruments: The Mc Gill Pain Questionnaire. Assessment Instruments: The Mc Gill Pain Questionnaire.

 The Visual Analogue The Visual Analogue

(12) POSTURAL INSTABILITY:(12) POSTURAL INSTABILITY:

Disturbed balance.Disturbed balance.

Greater problem in single limb stance.Greater problem in single limb stance.

 Assessment instrument : Timed up & go test. Assessment instrument : Timed up & go test.

Berg balance test.Berg balance test.

Functional reach.Functional reach.

Clinical Test for Sensory Interaction inClinical Test for Sensory Interaction in

Balance (CTSIB).Balance (CTSIB).

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

Page 105: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 105/186

DISEASEDISEASE

 Assessment instrument : Assessment instrument : Tinetti·s Tinetti·s Performance Oriented MobilityPerformance Oriented Mobility

 Assessment (POMA) Assessment (POMA)

(13) POSTURE :(13) POSTURE :--

Flexed or stooped.Flexed or stooped.

Kyphosis & cervicalKyphosis & cervical lordosislordosis..

 Assessment instrument : Postural grids or Plumb lines. Assessment instrument : Postural grids or Plumb lines.

Still photography.Still photography.

 Videotapes. Videotapes.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 106: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 106/186

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

(14) GAIT:(14) GAIT:--

Freezing episodes.Freezing episodes.

Shuffling gait pattern.Shuffling gait pattern.

Stride length, step width decreases.Stride length, step width decreases.

Cadence increased.Cadence increased.

(Gait should be examined during all movement directions;(Gait should be examined during all movement directions;forward, backward, sideward).forward, backward, sideward).

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

Page 107: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 107/186

DISEASEDISEASE

(15) AUTONOMIC CHANGES:(15) AUTONOMIC CHANGES: --

Excessive drooling (salivation).Excessive drooling (salivation).

Excessive sweating.Excessive sweating.

Greasy skin.Greasy skin.

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

Page 108: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 108/186

DISEASEDISEASE

CARDIORESPIRATORY EXAMINATIONCARDIORESPIRATORY EXAMINATION

Cardio respiratory endurance may be reduced from impaired respiratoryCardio respiratory endurance may be reduced from impaired respiratory

functions & long standing inactivity.functions & long standing inactivity.

(1)ABNORMAL BREATHING PATTERNS:(1)ABNORMAL BREATHING PATTERNS:--

Ribcage compliance & chest wall mobility decreases.Ribcage compliance & chest wall mobility decreases.

Restrictive breathing.Restrictive breathing.

Kyphosis present.Kyphosis present.

(2) ALTERED LUNG VOLUMES & CAPACITIES:(2) ALTERED LUNG VOLUMES & CAPACITIES: --

FVC, FEV, decreased.FVC, FEV, decreased.

RV, RA  W increased.RV, RA  W increased.

 TLC, VC decreased. TLC, VC decreased.

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

Page 109: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 109/186

DISEASEDISEASE

(3) ALTERED VITAL SIGNS:(3) ALTERED VITAL SIGNS: --

HRmax reduced.HRmax reduced.

Respiratory rate increased.Respiratory rate increased.

PaO2 is decreased.PaO2 is decreased.

BP decreased (orthostatic hypotension).BP decreased (orthostatic hypotension).

 Assessment instrument : 6 Minute walking test. Assessment instrument : 6 Minute walking test.

Exercise tolerance test.Exercise tolerance test.

Sphygmomanometer.Sphygmomanometer.

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

Page 110: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 110/186

DISEASEDISEASE

FUNCTIONAL STATUS:FUNCTIONAL STATUS:--

Difficulty in performing ADL.Difficulty in performing ADL.

 Activities having a rotational component are reduced or absent. Activities having a rotational component are reduced or absent.

 Assessment instrument : The functional independence measure Assessment instrument : The functional independence measure

Katz index of independence in activities of Katz index of independence in activities of 

daily life.daily life.

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

DISEASEDISEASE

Page 111: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 111/186

DISEASEDISEASE

GENERAL HEALTH MEASURES:GENERAL HEALTH MEASURES:--

Decrease in physical & social function.Decrease in physical & social function.

Decrease in emotional well being.Decrease in emotional well being.

 Assessment instrument: Rand 36 item health survey SF 36 Assessment instrument: Rand 36 item health survey SF 36

Sickness impact profile.Sickness impact profile.

SKIN INTEGRITY & CONDITION:SKIN INTEGRITY & CONDITION:--

Bruising & skin breakdown.Bruising & skin breakdown.

Pressure sore may be present in patient confined to bed.Pressure sore may be present in patient confined to bed.

FINGER DEXTERITY:FINGER DEXTERITY: --

Pt. May unable to button up three shirt buttons up to 3 minutes.Pt. May unable to button up three shirt buttons up to 3 minutes.

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

DISEASEDISEASE

Page 112: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 112/186

DISEASEDISEASE

OUTCOME MEASURESOUTCOME MEASURES

Outcome measure serves as an aid in charting and objectivelyOutcome measure serves as an aid in charting and objectively

assessing health problems, to evaluate preliminary treatmentassessing health problems, to evaluate preliminary treatment

effectiveness and make inventory of the patient problems for possibleeffectiveness and make inventory of the patient problems for possible

intervention.intervention.

 The KNGF development group Guidelines 2004, recommends the The KNGF development group Guidelines 2004, recommends the

following outcome for PD measurement:following outcome for PD measurement:

 The The RetropulsionRetropulsion test; For general impression of problems withtest; For general impression of problems withbalancebalance

 The MODIFIED Parkinson·s Activity scale(PAS) The MODIFIED Parkinson·s Activity scale(PAS)--for quality of for quality of 

movement during certainmovement during certain ADL;functional ADL;functional mobilitymobility

OUTCOME MEASURESOUTCOME MEASURES

Page 113: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 113/186

 Time up and go test(TUG) Time up and go test(TUG)--for functional mobility and balancefor functional mobility and balance

 The six minute walk test The six minute walk test-- for physical capacity in the absencefor physical capacity in the absence

of freezing.of freezing.

 The Ten The Ten--meter walk testmeter walk test-- To evaluate comfortable walking To evaluate comfortable walking

speed.speed.

GRADING OF PARKINSON·s DISEASEGRADING OF PARKINSON·s DISEASE

(1)(1) HOEHN & YAHR SCALE (1967).HOEHN & YAHR SCALE (1967).

(2)(2) HE UNIFIED PARKINSON·S DISEASE RATING SCALEHE UNIFIED PARKINSON·S DISEASE RATING SCALE ²  ² 

UPDRS (1987).UPDRS (1987).

(3)(3)  THE PARKINSON·S DISEASE QUESTIONNAIRE (PDQ THE PARKINSON·S DISEASE QUESTIONNAIRE (PDQ--39).39).

OUTCOME MEASURESOUTCOME MEASURES

Page 114: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 114/186

HOEHN AND YAHR SCALEHOEHN AND YAHR SCALE

STAGE 1STAGE 1 ²  ² Disability or functional impairment is usually absent orDisability or functional impairment is usually absent or

minimal.minimal.

  If present, unilateral involvement.  If present, unilateral involvement.

STAGE 2STAGE 2 ²  ² Bilateral or midline involvement.Bilateral or midline involvement.

-- Balance not disturbed.Balance not disturbed.

STAGE 3STAGE 3 ²  ² Impaired righting reflexes.Impaired righting reflexes.

-- Functionally restricted in some activities but patient canFunctionally restricted in some activities but patient can

live.live.

-- Disability is mild to moderateDisability is mild to moderate..

OUTCOME MEASURESOUTCOME MEASURES

Page 115: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 115/186

STAGE 4STAGE 4 ²  ² All symptoms present & severally disabled. All symptoms present & severally disabled.

-- Standing & walking possible only with assistance.Standing & walking possible only with assistance.

STAGE 5STAGE 5 ²  ² Confined to wheelchair or bed.Confined to wheelchair or bed.

MODIFIED HOEHN AND YAHR STAGINGMODIFIED HOEHN AND YAHR STAGING

STAGE 0 = No signs of disease.STAGE 0 = No signs of disease.

STAGE 1 = Unilateral disease.STAGE 1 = Unilateral disease.

STAGE 1.5 = Unilateral plus axial involvementSTAGE 1.5 = Unilateral plus axial involvement..

STAGE 2 = Bilateral disease, without impairment of balance.STAGE 2 = Bilateral disease, without impairment of balance.

STAGE 2.5 = Mild bilateral disease, with recovery on pull test.STAGE 2.5 = Mild bilateral disease, with recovery on pull test.

OUTCOME MEASURESOUTCOME MEASURES

Page 116: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 116/186

MODIFIED HOEHN AND YAHR STAGINGMODIFIED HOEHN AND YAHR STAGING

STAGE 3 = Mild to moderate bilateral disease; some posturalSTAGE 3 = Mild to moderate bilateral disease; some postural

instability; physically independent.instability; physically independent.

STAGE 4 = Severe disability; still able to walk or standSTAGE 4 = Severe disability; still able to walk or stand

unassisted.unassisted.

STAGE 5 =  Wheelchair bound or bedridden unless aided.STAGE 5 =  Wheelchair bound or bedridden unless aided.

UNIFIED PARKINSON·S DISEASE RATING SCALEUNIFIED PARKINSON·S DISEASE RATING SCALE

Page 117: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 117/186

It is a rating tool to follow the longitudinal course of PD.It is a rating tool to follow the longitudinal course of PD.

It is made up of :It is made up of :--

(a)(a) MentationMentation, Behavior & Mood., Behavior & Mood.

(b)(b)  ADL. ADL.

(c)(c) Motor sections.Motor sections.

 These are evaluated by interviewing the patient These are evaluated by interviewing the patient

 A total of 199 points are possible. A total of 199 points are possible.

199 points represents the worst (total disability) & 0 point199 points represents the worst (total disability) & 0 point

represents no disability.represents no disability.

 THE PARKINSON·S DISEASE QUESTIONNAIRE (PDQ 39) THE PARKINSON·S DISEASE QUESTIONNAIRE (PDQ 39)

Page 118: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 118/186

 The PDQ is a 39 items questionnaire. The PDQ is a 39 items questionnaire.

It focuses on the subjective reports of the impact of PD onIt focuses on the subjective reports of the impact of PD on

daily life.daily life.

 These are interviewed with patients. These are interviewed with patients.

Scored are given & summarized as Parkinson·s diseaseScored are given & summarized as Parkinson·s disease

Summary Index (PDSI).Summary Index (PDSI).

 ANALYSIS OF FINDINGS ANALYSIS OF FINDINGS

Page 119: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 119/186

Is physiotherapy indicated?Is physiotherapy indicated?

Can the guidelines be applied to this individual patient?Can the guidelines be applied to this individual patient?Physiotherapy will be indicated if the patient;Physiotherapy will be indicated if the patient;

11.. Is limited in one or more activities (transfers, posture, reaching andIs limited in one or more activities (transfers, posture, reaching and

grasping, balance and gait);grasping, balance and gait);2.2. Has (or has the risk of) a decreased physical capacity caused by inactivity;Has (or has the risk of) a decreased physical capacity caused by inactivity;

3.3. has an increased risk of falling or has fear to fall;has an increased risk of falling or has fear to fall;

44. Has an increased chance of pressure sores; or. Has an increased chance of pressure sores; or

5.5. has the need for information or advice on the disorder, natural course andhas the need for information or advice on the disorder, natural course and

 prognosis prognosis

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

DISEASEDISEASE

Page 120: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 120/186

DISEASEDISEASE

 AIMS OF PHYSIOTHERAPY TREATMENT AIMS OF PHYSIOTHERAPY TREATMENT

 According to Disease Progression According to Disease Progression

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

DISEASEDISEASE

Page 121: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 121/186

DISEASEDISEASE

PLAN OF TREATMENTPLAN OF TREATMENT

11. To increase safety and independence in the performance of . To increase safety and independence in the performance of 

activities, with the emphasis on:activities, with the emphasis on:

 Transfers; Transfers;

Posture;Posture;

Reaching and grasping;Reaching and grasping;

Balance;Balance; Gait;Gait;

2. To preserve or improve physical capacity;2. To preserve or improve physical capacity;

PLAN OF TREATMENTPLAN OF TREATMENT

Page 122: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 122/186

3.3. To prevent falling; To prevent falling;

4. To prevent pressure sores;4. To prevent pressure sores;

5. To stimulate insight into impairments in functions and5. To stimulate insight into impairments in functions and

limitations in activities, especially in the area of posture andlimitations in activities, especially in the area of posture and

movement.movement.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 123: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 123/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

 THERAPEUTIC PROCESS: THERAPEUTIC PROCESS:

GENERAL TREATMENT PRINCIPLESGENERAL TREATMENT PRINCIPLES

i.i. Location of the treatmentLocation of the treatment:: to improve functional

activity, it is recommended it preferably takes place at the

 patient home. This can also improve physical capacity

ii.ii. Involvement of care giverInvolvement of care giver

iii.iii.  Avoidance of dual tasking Avoidance of dual tasking

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 124: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 124/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

iv.iv. Multidisciplinary agreementMultidisciplinary agreement

 v. v. Frequency and duration of treatment:Frequency and duration of treatment: there are

indications that a period of  AT LEAST FOUR WEEKS  AT LEAST FOUR WEEKS is needed to

decrease limitations in functional activities (disability) while a

 period of AT AT LEAST EIGHT WEEKS LEAST EIGHT WEEKS of aerobic exercises and other

exercises is necessary to improve physical capacity, in which period

of a low frequency of treatment is sufficient for example once a

 week to adjust exercise program. (Kamsma et al., 1995; Comelle et

al,. 1994; Dam et al., 1996; Patti, 1996; Thaut et al., 1996)

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 125: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 125/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

 vi. vi.  Time of treatment: Time of treatment:

      Exercises in PD patients can be performed in the On- as

 well as in the Off- period (including cognitive movement

strategies and cueing strategies)

      It is advisable also to train physical capacity (including

strength) in patient with PD during the On- period,

because at this time, neurological problems have less

influence on the level of performance.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 126: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 126/186

PARKINSON S DISEASEPARKINSON S DISEASE

 vii. vii.  Tempo of exercising: Tempo of exercising: in cognitive impairment and

fatigue. Tempo and schedule of treatment need to be

adjusted.

 viii. viii. Recognising a response of fluctuation:Recognising a response of fluctuation: physical

therapist should draw the patient attention to response

fluctuation.

ix.ix. Contraindications:Contraindications:

           Deep brain stimulation (S WD, M WD, electromagnetic pulses,Deep brain stimulation (S WD, M WD, electromagnetic pulses,

electromagnetic fields)electromagnetic fields)

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 127: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 127/186

PARKINSON S DISEASEPARKINSON S DISEASE

ix.ix.

Contraindications:Contraindications:           FreezingFreezing ² hydrotherapy is contraindicated in freezing.

           Mental impairmentMental impairment: Impairment in cognition (e.g.

 poor memory, dementia and severe hallucinations),

 personality and attention are relative contraindications for

the treatment of health problems related to PD.

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

DISEASEDISEASE

Page 128: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 128/186

DISEASEDISEASE

EvidenceEvidence--BasedBased Analysis Analysis of of PhysicalPhysical

 Therapy Therapy inin Parkinson·sParkinson·s DiseaseDisease with with

RecommendationsRecommendations forfor PracticePractice andandResearchResearch.. ((keuskeus etet alal..,, 20062006))

Page 129: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 129/186

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 130: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 130/186

 TREATMENT STRATEGIES OR MEANS TREATMENT STRATEGIES OR MEANS

For PD patients with sufficient understanding, insight, and

memory

Cognitive movement strategies

Cueing strategies

Modifying coping strategies.

 Are recommended treatment means based on Hoehn and Yahr

classification of PD into three phases as related to treatment

goal.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 131: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 131/186

Cognitive movement strategieCognitive movement strategiess

Cognitive movement strategies can be applied by physical therapist

to improve TRANSFERS. (Morris, 2000; Kamsma et al., 1995;

Iansek, 1999; Nieuwboer, 2001; Muller et al., 1997)

In Cognitive movement strategies, complex (automatic) activities are

transformed to a number of separate elements which are executed in

a defined sequence and which consist of relatively simple movement

elements.

 This will prevent dual tasking during complex (automatic) activities

in daily life. Performance is consciously controlled and can be

guided by using CUES in initiation.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

Page 132: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 132/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

Cognitive movement strategiesCognitive movement strategiesExample; Rising from a chair.Example; Rising from a chair.

 place your hands on the arms or the side of the seat; place your hands on the arms or the side of the seat;

move your feet towards the chair (just in front of the chair legs, twomove your feet towards the chair (just in front of the chair legs, two

fists apart);fists apart);

shift your hips to the edge of the chair;shift your hips to the edge of the chair;

bend your trunk (not too far, nose above the knees);bend your trunk (not too far, nose above the knees);

rise gently, from your legs, let your hands lean on the arms of therise gently, from your legs, let your hands lean on the arms of the

chair, the seat or your thighs, and then extend your trunk completelychair, the seat or your thighs, and then extend your trunk completely

(if necessary, make use of a visual cue). In case of starting problems(if necessary, make use of a visual cue). In case of starting problems

rock back and forth a few times and rise at the third count.rock back and forth a few times and rise at the third count.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKI SO ·S DIS ASPARKI SO ·S DIS AS

Page 133: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 133/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

Cueing strategiesCues are used to complete or replace the fundamentalCues are used to complete or replace the fundamental

 problems of internal control in PD patient as in performance of  problems of internal control in PD patient as in performance of 

automatic and repetitive movements.automatic and repetitive movements.

Cues are stimuli from the environment or stimuli generated byCues are stimuli from the environment or stimuli generated by

the patient which increase attention and facilitate (automatic)the patient which increase attention and facilitate (automatic)

movements.movements.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 134: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 134/186

PARKINSON·S DISEASEPARKINSON·S DISEASECueing StrategiesCueing Strategies

CUESCUES

RhythmicalRhythmical

recurring cuesrecurring cues

OneOne--off cuesoff cues

Internal cueInternal cue

e.g. bow,e.g. bow,

stretch, wavestretch, wave.

ExternalExternal

CueCue

NonNon--moving stimulimoving stimuli

e.g. sound of metronome,e.g. sound of metronome,

Stripes on the floor,Stripes on the floor, A grip of a walking stick. A grip of a walking stick.

Moving stimuliMoving stimuli

e.g. light of laser pen,e.g. light of laser pen,

 A moving foot, A moving foot,

 A falling bunch of keys A falling bunch of keys

Example of cueing strategy to improve gaitExample of cueing strategy to improve gait

Freezing at the DoorwayFreezing at the Doorway

Page 135: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 135/186

Example of cueing strategy to improve gaitExample of cueing strategy to improve gait

F i t th D ` h d li ht f tiF i t th D ` h d li ht f ti

Page 136: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 136/186

Freezing at the Doorway` arrow show red light for correctionFreezing at the Doorway` arrow show red light for correction

Solution Solution ²  ² a red line is added a red line is added 

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 137: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 137/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

RHYTHMICALRHYTHMICAL RECURRINGRECURRING CUESCUES areare givengiven asas aa

continuouscontinuous rhythmicalrhythmical stimulus,stimulus, which which cancan serveserve asas aa controlcontrol

mechanismmechanism forfor walking walking..

 The The distancedistance betweenbetween (frequency(frequency of)of) rhythmicrhythmic cuescues duringduring

 walking walking will will bebe basedbased onon thethe numbernumber of of stepssteps neededneeded toto

 perform perform thethe Ten Ten--metermeter walk  walk testtest atat comfortablecomfortable pace pace..

ONEONE- - OFF OFF CUES CUES  areare usedused toto keepkeep balance,balance, forfor exampleexample

 when when performing performing transfertransfer andand forfor initiatinginitiating ADL ADL oror when when

gettinggetting startedstarted againagain afterafter aa period period of of freezingfreezing..

PHYSIOTHERAPY MANAGEMENT OF PARKINSON·SPHYSIOTHERAPY MANAGEMENT OF PARKINSON·S

DISEASEDISEASE

Page 138: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 138/186

DISEASEDISEASE

Rhythmic recurring cuesRhythmic recurring cues

 Auditory Auditory

the patient moves on music of a walkmanthe patient moves on music of a walkman

the patient moves on rhythmical ticking of  the patient moves on rhythmical ticking of 

a metronomea metronome

the patient or someone else sings or counts the patient or someone else sings or counts

 Visual Visual the patient follows another person the patient follows another person

the patient walks over stripes on the floor or the patient walks over stripes on the floor or

over stripes he projects to himself withover stripes he projects to himself with

a laser pena laser pen

the patient walks with an inverted walking the patient walks with an inverted walking--

stick and has to step over the gripstick and has to step over the grip

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 139: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 139/186

PARKINSON S DISEASEPARKINSON S DISEASE

Rhythmic recurring cuesRhythmic recurring cues Tactile Tactile thethe patient patient tapstaps hishis hiphip oror legleg

OneOne--off cuesoff cues

 Auditory Auditory initiation of movement, for example, initiation of movement, for example,

stepping out at the third countstepping out at the third count

 Visual Visual initiation of movement, for example, by initiation of movement, for example, by

stepping over some else·s foot, an object onstepping over some else·s foot, an object onthe floor or an inverted walkingthe floor or an inverted walking--stick stick 

maintenance of posture, for example, by maintenance of posture, for example, by

using a mirror or by focusing on an objectusing a mirror or by focusing on an object

(clock, painting) in the environment(clock, painting) in the environment

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 140: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 140/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

OneOne--off cuesoff cues

CognitiveCognitive initiation of movement (and continuation initiation of movement (and continuation

of walking), for example, by focusing onof walking), for example, by focusing onthe spot he wants to go to, and not on thethe spot he wants to go to, and not on the

doorway he has to go throughdoorway he has to go through

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 141: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 141/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

RECOMMENDATIONS FROM EVIDENCE BASEDRECOMMENDATIONS FROM EVIDENCE BASEDRESEARCHRESEARCH

EARLY OR MAINTENANCE PHASEEARLY OR MAINTENANCE PHASE

Stimulate balanceStimulate balance

Goal: to optimize balance and training strength.Goal: to optimize balance and training strength.

Strategy : Exercises for balance and training strength.Strategy : Exercises for balance and training strength.

e.g.e.g. ²  ²  Taichi (two group sessions a week for fifteen weeks) Taichi (two group sessions a week for fifteen weeks)

-- walking outside three times a week, completed with a home walking outside three times a week, completed with a home

exercise program (30 minutes, 3 times a week).exercise program (30 minutes, 3 times a week).

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 142: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 142/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

 Taichi for balance training ,perception of posture and coordination of arms

and legs and backward and lateral large step.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 143: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 143/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

  Walking on toes strengthening exercises to the legs  Walking on toes strengthening exercises to the legs

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 144: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 144/186

PARKINSON·S DISEASEPARKINSON·S DISEASE

Stepping over an objectStepping over an object

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 145: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 145/186

PARKINSON S DISEASEPARKINSON S DISEASE

 These decreases the number of falls These decreases the number of falls

(b) Exercise to increase the mobility of among others, neck, knees and(b) Exercise to increase the mobility of among others, neck, knees and

hips.hips.

-- Referral to occupational therapy to identify and alter any changesReferral to occupational therapy to identify and alter any changes

present in the home environment.present in the home environment.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 146: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 146/186

PARKINSON S DISEASEPARKINSON S DISEASE

PREVENTION OF INACTIVITY OR MAINTENANCEPREVENTION OF INACTIVITY OR MAINTENANCEOF PHYSICAL CAPACITY.OF PHYSICAL CAPACITY.

Goal: Maintenance or improvement of physical capacity.Goal: Maintenance or improvement of physical capacity.

Strategy: providing information on the importance of Strategy: providing information on the importance of exercising or playing sports, training of aerobics capacity,exercising or playing sports, training of aerobics capacity,

muscle strength (with emphasis on the muscles of the trunk muscle strength (with emphasis on the muscles of the trunk 

and legs), joint mobility (among others axial) and muscleand legs), joint mobility (among others axial) and musclelength (among others, muscles of the calf and hamstrings)length (among others, muscles of the calf and hamstrings)

 A THERA CYCLE: to improve physical capacity A THERA CYCLE: to improve physical capacity

Page 147: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 147/186

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 148: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 148/186

PROGRESSIVE RESISTANCEPROGRESSIVE RESISTANCE STRENGTHENING EXERCISESSTRENGTHENING EXERCISES

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 149: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 149/186

PARKINSON S DISEASEPARKINSON S DISEASE

 Joint mobility training Joint mobility training

Exercise programs focused on improving joint mobility,Exercise programs focused on improving joint mobility,

combined with training of gait and balance, improve motor skills.combined with training of gait and balance, improve motor skills.

( (ComelleComelle et al., 1994; Patti et al., 1996;et al., 1994; Patti et al., 1996; PachettiPachetti et al., 2000;et al., 2000;

MarcheseMarchese et al., 2000 ).et al., 2000 ).

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 150: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 150/186

PARKINSON S DISEASEPARKINSON S DISEASE

Improves ADL (Improves ADL (ComelleComelle et al., 1994; Patti et al., 1996;et al., 1994; Patti et al., 1996;

PachettiPachetti et al., 2000;et al., 2000; FormisanoFormisano et al., 1992; Palmer et al., 1986)et al., 1992; Palmer et al., 1986)

Improves mental functioning (Improves mental functioning (ComelleComelle et al., 1994; Patti etet al., 1994; Patti et

al., 1996).al., 1996).

ShenkmanShenkman et al., 1998 shows that exercise program focusedet al., 1998 shows that exercise program focused

at improving joint mobility and coordinated movementat improving joint mobility and coordinated movement

incorporated in ADL improves functional axial rotation andincorporated in ADL improves functional axial rotation and

reach (balance).reach (balance).

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 151: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 151/186

PARKINSON S DISEASEPARKINSON S DISEASE

 Training of strength Training of strengthExercise program which are among others, focused onExercise program which are among others, focused on

improving muscle strength (of the lower extremities and trunk)improving muscle strength (of the lower extremities and trunk)

Page 152: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 152/186

 Trunk rotation exercises

LUNGES

 ANKLE JOINT MOBILITY 

SQUATTING EXERCISES

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 153: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 153/186

PARKINSON S DISEASEPARKINSON S DISEASE

May also improve muscle strength in patients with PD (in earlyMay also improve muscle strength in patients with PD (in early

to middle phase). (Reuter et al., 1999; Scandalis et al., 2001).to middle phase). (Reuter et al., 1999; Scandalis et al., 2001).

 Training aerobic Capacity Training aerobic Capacity

 Aerobic exercise that improves aerobic capacity also improve Aerobic exercise that improves aerobic capacity also improve

motor skills of patient with PD in the early phase (Reuter et al.,motor skills of patient with PD in the early phase (Reuter et al.,

1999;1999; BaatileBaatile et al., 2000; Bergen et al., 2002).et al., 2000; Bergen et al., 2002).

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 154: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 154/186

PARKINSON S DISEASEPARKINSON S DISEASE

 Training aerobic capacity  Training aerobic capacity  Group therapy

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 155: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 155/186

PARKINSON S DISEASEPARKINSON S DISEASE

Fall PreventionFall Prevention

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 156: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 156/186

PARKINSON S DISEASEPARKINSON S DISEASE

Mid or Complex PhaseMid or Complex PhaseCognitive movement strategies improve transfers

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 157: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 157/186

PARKINSON S DISEASEPARKINSON S DISEASE

CUEING STRATEGIES TO IMPROVE GAIT: As diseaseCUEING STRATEGIES TO IMPROVE GAIT: As disease

 progresses and medication is not as effective, some people progresses and medication is not as effective, some people

 present freezing of gait. One common problem is to freeze present freezing of gait. One common problem is to freeze

 when trying to go through a when trying to go through a doorway. It is possible todoorway. It is possible to

overcome this problem with a simple visual cue, such as a lineovercome this problem with a simple visual cue, such as a line

on the floor. This cue attracts attention to the task, and theon the floor. This cue attracts attention to the task, and the

 person can step over it. Another strategy to overcome freezing person can step over it. Another strategy to overcome freezingof gait is the use of auditory cues, such as a metronome, thatof gait is the use of auditory cues, such as a metronome, that

can be adjusted to the person·s walking rhythm.can be adjusted to the person·s walking rhythm.

Page 158: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 158/186

Page 159: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 159/186

Solution Solution ²  ² a red line is added a red line is added 

Improving gait using modified footwearImproving gait using modified footwear

Page 160: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 160/186

PhotoboardsPhotoboards providing insight to stance phase function. In both providing insight to stance phase function. In both photoboards photoboards, a, a

 physiotherapist can be seen walking alongside the patient and a walking stick  physiotherapist can be seen walking alongside the patient and a walking stick is being used. The top strip shows the unmodified footwear position and theis being used. The top strip shows the unmodified footwear position and the

bottom strip shows the modified footwear position.bottom strip shows the modified footwear position.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 161: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 161/186

Normalizing body posture and upper limb functionNormalizing body posture and upper limb function::

Cueing and cognitive movement strategies are creatively usedCueing and cognitive movement strategies are creatively used

in physiotherapy to design exercises to improve posture, suchin physiotherapy to design exercises to improve posture, such

as straightening the back an maintaining posture by looking atas straightening the back an maintaining posture by looking at

a target at eye level, or training functional arm movements,a target at eye level, or training functional arm movements,

such as drinking from a cup by dividing the complex sequencesuch as drinking from a cup by dividing the complex sequence

into different steps and practicing each step separately.into different steps and practicing each step separately.

Balance training could include stepping on the spot whileBalance training could include stepping on the spot while

lifting the knees up high, following the sound of a metronome.lifting the knees up high, following the sound of a metronome.

Page 162: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 162/186

Boxing:  Anticipatory postural adjustments, postural corrections, fast arm and footBoxing:  Anticipatory postural adjustments, postural corrections, fast arm and foot

motions, backward walking, timing, sequencing actionsmotions, backward walking, timing, sequencing actions

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 163: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 163/186

Late (Palliative) PhaseLate (Palliative) Phase Aim Aim ²  ² Prevention of ComplicationsPrevention of Complications

DYSKINESIASDYSKINESIAS: One of the complications in the late stage of 

PD is severe unpredictable fluctuations and dyskinesias.Relaxation techniques, which include breathing exercises and

correct posture, are effective in some patients. They have only a

short-term effect of about five to 10 minutes, but despite this, patients should be allowed to enjoy a few minutes of rest or a

nap, which will make a difference to their overall quality of life.

PHYSIOTHERAPY MANAGEMENT OFPHYSIOTHERAPY MANAGEMENT OF

PARKINSON·S DISEASEPARKINSON·S DISEASE

Page 164: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 164/186

 W  ALKING  AIDS: W  ALKING  AIDS: Stimulating mobility as much as

 possible is a goal in physiotherapy.  Walking is encouraged,

sometimes with the help of walking aids. Not every walking aid

is appropriate and some are potentially dangerous if given to

the wrong person. Sometimes using a walking aid at certain

 periods of the day under close supervision could maintain a

certain level of mobility, with all of the attendant benefits.

 Walking Aids Walking Aids

Page 165: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 165/186

 W ALKING AID

Page 166: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 166/186

 W ALKING W ALKING AIDS AIDS

Page 167: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 167/186

  TREATMENT TECHNIQUES  TREATMENT TECHNIQUES

Page 168: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 168/186

Keep Moving Exercise ProgramKeep Moving Exercise Program

METERS(Movement Enablement TMETERS(Movement Enablement T hroughhrough Exercise Regimes)Exercise Regimes)(Plant et al. ,2001 )(Plant et al. ,2001 )

  Task specific approach (Morris,2000 )  Task specific approach (Morris,2000 )

Systematic approach( Systematic approach(schenkmanschenkman et al.,1989 and 1996 )et al.,1989 and 1996 )

SensorimotorSensorimotor Agility Exercise Program Agility Exercise Program Tiachi Tiachi

Kayaking Kayaking 

 A

gility  A

gility Boxing Boxing 

LungesLunges

PrepilatePrepilate (king and Horak,2009)(king and Horak,2009)

 TREATMENT TECHNIQUES TREATMENT TECHNIQUES

Relaxation techniquesRelaxation techniques

Page 169: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 169/186

e o ec q ese o ec q es

Autogenic Autogenic Progressive muscleProgressive muscle

 Visualization Visualization

 Tiachi Tiachi

MusicMusic

Light stoking massageLight stoking massage

HarthaHartha yogayoga

ExerciseExercise ²  ²  Alexander technique(stallibrass,1997) Alexander technique(stallibrass,1997)

Deep Breathing techniqueDeep Breathing technique

 Vestibular rehabilitation Therapy  Vestibular rehabilitation Therapy 

CONCLUSIONCONCLUSION

EVALUATIONEVALUATION

Page 170: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 170/186

EVALUATIONEVALUATION

PATIENTS SPECIFIC COMPLAINTS QUESTIONNAIRE,PATIENTS SPECIFIC COMPLAINTS QUESTIONNAIRE,

MEASUREMENT OF THE ¶GLOBAL PERCEIVEDMEASUREMENT OF THE ¶GLOBAL PERCEIVED

EFFECT· SHOULD ALSO BE USEDEFFECT· SHOULD ALSO BE USED

 AFTERCARE AFTERCARE Preservation of improved activities in daily livingPreservation of improved activities in daily living

Check Check--upup

Final evaluationFinal evaluation

ReportingReporting

REFERENCESREFERENCES B tilB til JJ L n b inL n b in WE W r F M l n CWE W r F M l n C J tJ t MBMB

Page 171: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 171/186

..

BaatileBaatile J, J, LangbeinLangbein WE, Weaver F, Maloney C, WE, Weaver F, Maloney C, Jost Jost MB.MB.

Effect of exercise on perceived quality of life of Effect of exercise on perceived quality of life of individuals with Parkinson·s disease. Jindividuals with Parkinson·s disease. J RehabilRehabil ResResDev 2000 Sep;37(5):529Dev 2000 Sep;37(5):529--3434

Bergen JL,Bergen JL, Toole Toole T, Elliott III RG, Wallace B, Robinson T, Elliott III RG, Wallace B, Robinson

K, Maitland CG.  Aerobic exercise interventionK, Maitland CG.  Aerobic exercise interventionimproves aerobicimproves aerobic

BloemBloem BR, Beckley DJ, vanBR, Beckley DJ, van Dijk Dijk JG, JG, ZwindermanZwinderman  AH, AH,RemlerRemler MP,MP, RoosRoos R  A. Influence of R  A. Influence of dopaminergicdopaminergicmedication on automatic postural responses andmedication on automatic postural responses andbalance impairment in Parkinson·s disease.balance impairment in Parkinson·s disease. Mov Mov DisordDisord 1996 Sep;11(5):5091996 Sep;11(5):509--21.21.

REFERENCEREFERENCE

BloemBloem BR, vanBR, van Vugt Vugt JP, Beckley DJ. Postural JP, Beckley DJ. Postural

Page 172: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 172/186

instability and falls in Parkinson·s disease. A

dv instability and falls in Parkinson·s disease. A

dv NeurolNeurol 2001;87:209 223.2001;87:209 223.

BloemBloem BR, Beckley DJ, vanBR, Beckley DJ, van Dijk Dijk JG, JG, ZwindermanZwinderman AH, AH, RemlerRemler MP,MP, RoosRoos R  A. Influence of R  A. Influence of 

dopaminergicdopaminergic medication on automatic posturalmedication on automatic postural

responses and balance impairment in Parkinson·sresponses and balance impairment in Parkinson·sdisease.disease. Mov Mov DisordDisord 1996 Sep;11(5):5091996 Sep;11(5):509--21.21.

BloemBloem BR,BR, GrimbergenGrimbergen Y  A, Cramer M, Y  A, Cramer M, Willemsen WillemsenM,ZwindermanM,Zwinderman AH. Prospective assessment of  AH. Prospective assessment of falls in Parkinson·s disease. Jfalls in Parkinson·s disease. J NeurolNeurol 2001 2001 

Nov;248( 

11 ):95

0Nov;

248( 

11 ):95

0--88

REFERENCEREFERENCE

Chartered Society of Physiotherapy ( 2001 )Chartered Society of Physiotherapy ( 2001 )

Page 173: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 173/186

y y py ( )y y py ( )

¶Effectiveness bulletin: Neurology: Parkinson·s¶Effectiveness bulletin: Neurology: Parkinson·sdisease, Multiple Sclerosis and severe traumaticdisease, Multiple Sclerosis and severe traumatic

brain injury·brain injury· Effectiveness Bulletin  Effectiveness Bulletin ²  ² Evidence  Evidence - -b ased b ased 

Practice Practice  Vol Vol 3, Issue 2, pp13, Issue 2, pp1 ²  ²33

ChessonChesson R. Psychosocial aspects of measurement.R. Psychosocial aspects of measurement.

Physiotherapy 1998;84(9):435Physiotherapy 1998;84(9):435--8.8.

ComellaComella CL, Stebbins GT, BrownCL, Stebbins GT, Brown--Toms N, Goetz Toms N, Goetz

CG. Physical therapy and Parkinson·s disease: aCG. Physical therapy and Parkinson·s disease: a

controlled clinical trial. Neurology 1994 Mar;44(3controlled clinical trial. Neurology 1994 Mar;44(3Pt 1 ):376Pt 1 ):376--88

REFERENCEREFERENCE Dam M,Dam M, Tonin Tonin P,P, CassonCasson S,S, BraccoBracco F,F, PironPiron L,L,

Page 174: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 174/186

PizzolatoPizzolato G,G, etaletal. Effects of conventional and. Effects of conventional andsensory sensory--enhancedenhanced physiotherapyonphysiotherapyon disability of disability of 

Parkinson·s disease patients.  Adv Parkinson·s disease patients.  Adv NeurolNeurol1996;69:5511996;69:551--5.5.

FormisanoFormisano R,R, PratesiPratesi L,L, ModarelliModarelli F T,F T, BonifatiBonifati V, V,MecoMeco G.RehabilitationG.Rehabilitation andand Parkinson·sdiseaseParkinson·sdisease..

Scand JScand J RehabilRehabil Med1992 Sep;24(3):157Med1992 Sep;24(3):157--60.60.

Garrett N A,Garrett N A, BrasureBrasure M, Schmitz KH, Schultz MM,M, Schmitz KH, Schultz MM,HuberHuber MR.PhysicalMR.Physical inactivity: direct cost to ainactivity: direct cost to a

health plan.  Am Jhealth plan.  Am J Prev Prev Med2004;27:304Med2004;27:304 ²  ²309.309.

REFERENCEREFERENCE

Global Parkinson·s Disease Survey Steering Committee.Global Parkinson·s Disease Survey Steering Committee.

Page 175: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 175/186

Factors impacting on quality of life in Parkinson·sFactors impacting on quality of life in Parkinson·sdisease: results from an international survey.disease: results from an international survey. Mov Mov DisordDisord 2002;17( 1 ):602002;17( 1 ):60--7.7.

GrimbergenGrimbergen Y, Y, MunnekeMunneke M,M, BloemBloem BR. Falls in Parkinson·sBR. Falls in Parkinson·s

disease. Review.disease. Review. CurrCurr OpinOpin NeurolNeurol 2004;17:4052004;17:405²  ² 15.15. GuttmanGuttman M,KishM,Kish JS and Furukawa Y( 2003);Current concept JS and Furukawa Y( 2003);Current concept

in thein the diagnosis and management of diagnosis and management of parkinson·sparkinson·s diseasediseaseCM A J 2003,168:3CM A J 2003,168:3

HeuvelHeuvel CMF van den,CMF van den, Vogels Vogels EMHM,EMHM, Mellink Mellink M,M,DijkstraDijkstra ZM,PietersZM,Pieters HM.HM. Handreiking Handreiking verslaggeving  verslaggeving..http://www.paramedisch.org http://www.paramedisch.org ..

REFERENCEREFERENCE Iansek Iansek R. Interdisciplinary rehabilitationR. Interdisciplinary rehabilitation inParkinson·sinParkinson·s disease.disease.

Page 176: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 176/186

In: Stern GM, editor.  Advances in Neurology. Parkinson·sIn: Stern GM, editor.  Advances in Neurology. Parkinson·s

disease. 80 ed.disease. 80 ed. PhilidelphiaPhilidelphia:: LippincotLippincot Williams & Williams & Wilkins;1999. p. 555 Wilkins;1999. p. 555--99

 Jankovic Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, J, McDermott M, Carter J, Gauthier S, Goetz C,

GolbeLGolbeL, et al. Variable expression of Parkinson·s disease:, et al. Variable expression of Parkinson·s disease:a basea base--line analysis of the D A T A TOP cohort. Theline analysis of the D A T A TOP cohort. TheParkinson Study Parkinson Study Group.Neurology Group.Neurology 1990 Oct;40( 10 ):15291990 Oct;40( 10 ):1529--34.34.

KamsmaKamsma YPT, YPT, BrouwerBrouwer WH, WH, LakkeLakke JPW F. Training of  JPW F. Training of compensation strategies for impaired gross motor skills incompensation strategies for impaired gross motor skills inParkinson·s disease.Parkinson·s disease. PhysiotherPhysiother Theory  Theory PractPract 1995;11:2091995;11:209--29.29.

REFERENCEREFERENCE KeusKeus SHJ,SHJ, BloemBloem BR,BR, Verbaan Verbaan D, et al. Physiotherapy inD, et al. Physiotherapy in Parkinson'sParkinson's

disease tilisation and patient satisfactiondisease tilisation and patient satisfaction JJ Ne rolNe rol

Page 177: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 177/186

disease: utilisation and patient satisfaction.disease: utilisation and patient satisfaction. J  J NeurolNeurol

2004;251:6802004;251:680 ²  ² 687.687. King L A,King L A, Horak Horak FB. Delaying mobility disability in people withFB. Delaying mobility disability in people with

Parkinson disease using aParkinson disease using a sensorimotorsensorimotor agility exercise programagility exercise program. . 

PhysTher PhysTher . 2009;89:384. 2009;89:384²  ²393.393.

KNGF

Guidelines for Physical Therapy inKNGF

Guidelines for Physical Therapy in Parkinson·s disease,Parkinson·s disease,Supplement to theSupplement to the D utch Journal of Physiotherapy D utch Journal of Physiotherapy , 2004;11, 2004;11

LaarLaar Tv  Tv,, Wolters Wolters ECMJ.ECMJ. CognitieveCognitieve stoornissenstoornissen enen psychosepsychose bijdebijdeziekteziekte van Parkinson. van Parkinson. DimensiesDimensies inin dementiedementie 2002;2:32002;2:3--7.7.

MathiesonMathieson I,CurranI,Curran S,HallamS,Hallam S,CorneS,Corne J: Improving gait performance J: Improving gait performancein Parkinson·sin Parkinson·s disease:adisease:a case report suggesting a role forcase report suggesting a role for

footwear modifications. physiotherapy 94( 2008)85footwear modifications. physiotherapy 94( 2008)85--8888

REFERENCEREFERENCE

MarcheseMarchese R,R, DiverioDiverio M,M, ZucchiZucchi F,F, LentinoLentino C,C,

Page 178: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 178/186

 A

bbruzzese A

bbruzzese G. The role of sensory cues in theG. The role of sensory cues in therehabilitation of rehabilitation of parkinsonianparkinsonian patients: apatients: a

comparison of two physical therapy protocols.comparison of two physical therapy protocols.Mov Mov DisordDisord 2000 Sep;15(5):8792000 Sep;15(5):879--83.83.

Mclnerney Mclnerney--LeoLeo  AMS,Gwinn AMS,Gwinn--Hardy; and NussbaumHardy; and NussbaumB( 2004):Prevalence of B( 2004):Prevalence of parkinson·sparkinson·s Disease inDisease inpopulations of  Africa  Ancestry ; A Review Jpopulations of  Africa  Ancestry ; A Review J NatlNatl

Med  Assoc 2004;96:974Med  Assoc 2004;96:974--979979 Management of Parkinson·s disease: an evidenceManagement of Parkinson·s disease: an evidence--

based review .based review .Mov Mov DisordDisord 2002;17(Suppl. 4):S12002;17(Suppl. 4):S1 ²  ² 

S166

.4.S166

.4.

REFERENCEREFERENCE

Morris M et al ( 1998) ¶The role of the physiotherapistMorris M et al ( 1998) ¶The role of the physiotherapist

Page 179: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 179/186

in quantifying movement fluctuations inin quantifying movement fluctuations inParkinson·s disease·Parkinson·s disease· Australian Physiotherapy  Australian Physiotherapy 44,10544,105²  ² 114114

Morris ME. Movement disorders in people withMorris ME. Movement disorders in people with

Parkinson disease: a model for physical therapy.Parkinson disease: a model for physical therapy.PhysPhys Ther Ther 2000 Jun;80( 6 ):5782000 Jun;80( 6 ):578--97.97.

Morris M,Morris M, Iansek Iansek R, Smithson F,R, Smithson F, HuxhamHuxham F. PosturalF. Postural

instability in Parkinson·s disease: a comparisoninstability in Parkinson·s disease: a comparison with and without a concurrent with and without a concurrent task. Gait Posturetask. Gait Posture2000 Dec;12(3):2052000 Dec;12(3):205--16.16.

REFERENCEREFERENCE Muller V, Mohr B, Rosin R,Muller V, Mohr B, Rosin R, PulvermullerPulvermuller F, Muller F,F, Muller F, BirbaumerNBirbaumerN..

ShortShort term effects ofterm effects of behavioralbehavioral treatment on movement initiationtreatment on movement initiation

Page 180: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 180/186

ShortShort--term effects of term effects of behavioralbehavioral treatment on movement initiationtreatment on movement initiation

and postural control in Parkinson·s disease: a controlled clinicaland postural control in Parkinson·s disease: a controlled clinicalstudy.study. Mov Mov DisordDisord 1997 May;12(3):3061997 May;12(3):306--1414

Muller J,Muller J, Wenning  Wenning GK,GK, Jellinger Jellinger K, McKee  A,K, McKee  A, PoewePoewe W, W, LitvanLitvan

Progression of Progression of HoehnHoehn andand Yahr Yahr stages instages in ParkinsoniandisordersParkinsoniandisorders: a: aclinic pathologic study. Neurology 2000 Sep 26;55( 6 ):888clinic pathologic study. Neurology 2000 Sep 26;55( 6 ):888--9191

NieuwboerNieuwboer A, de A, de Weerdt Weerdt W, Dom R, W, Dom R, Truyen Truyen M,M, Janssens Janssens L,KamsmaL,Kamsma The effect of a home physiotherapy  The effect of a home physiotherapy programforprogramfor persons withpersons with

Parkinson·s disease. JParkinson·s disease. J RehabilRehabil Med 2001Nov;33( 6 ):266Med 2001Nov;33( 6 ):266--72.72.

Olanow Olanow CW, Watts RL,CW, Watts RL, KollerKoller WC.  An algorithm (decision WC.  An algorithm (decision treefortreefor thethe

management of Parkinson·s disease ( 2001 ):management of Parkinson·s disease ( 2001 ): treatmentguidelinestreatmentguidelines..Neurology 2001 Jun;56( 11 Neurology 2001 Jun;56( 11 SupplSuppl 5):S15):S1--S8 8S8 8

OkubadejoOkubadejo UN,OjoUN,Ojo OO,andOO,and OshinaikeOshinaike OO( 2010 ): clinical profile of OO( 2010 ): clinical profile of ParkinsonismParkinsonism andand parkinson·sparkinson·s disease indisease in lagoslagos, south western, south western

REFERENCEREFERENCE OsuntokunOsuntokun BO,BO, BademosiBademosi O:O: Parkinsonism in the NigerianParkinsonism in the Nigerian

African:aAfrican:a prospective study of 217 patientsprospective study of 217 patients EastEast AfrAfr Med JMed J 19791979

Page 181: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 181/186

 African:a African:a prospective study of 217 patients. prospective study of 217 patients. East  East Afr  Afr Med J  Med J 1979,1979,

56:56:597597--607607 PacchettiPacchetti C, Mancini F,C, Mancini F,  Aglieri Aglieri R,R, FundaroFundaro C,C, MartignoniMartignoni E,NappiE,Nappi G.G.

 Active music therapy in Parkinson·s disease: Active music therapy in Parkinson·s disease: anintegrativeanintegrative methodmethod

for motor and emotionalfor motor and emotional rehabilitation.Psychosomrehabilitation.Psychosom MedMed2000;62(3):3862000;62(3):386--93.93.

Patti F. Effects of rehabilitation therapy onPatti F. Effects of rehabilitation therapy on ParkinsonsParkinsons· disability and· disability andfunctional independence . Jfunctional independence . J NeurolNeurol RehabilRehabil 1996;14(4):2231996;14(4):223--31.31.

Plant R, Jones D, Hutchinson  A, Thomson J,  AshburnPlant R, Jones D, Hutchinson  A, Thomson J,  Ashburn  A,Loader A,Loader S, et al.S, et al.Physiotherapy in Parkinson·s diseasePhysiotherapy in Parkinson·s disease -- referral,contactreferral,contact and dischargeand discharge

patterns.patterns. MovDisordMovDisord 2000;15 (Suppl3):1712000;15 (Suppl3):171

REFERENCEREFERENCE Plant R & Jones D ( 2001 ) Guidelines for physiotherapy with Parkinson·sPlant R & Jones D ( 2001 ) Guidelines for physiotherapy with Parkinson·s

disease. London: Institute of Rehabilitation, University of Northumbriadisease. London: Institute of Rehabilitation, University of Northumbria

Page 182: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 182/186

, y, y

Plant R ( 2000

 ) Physiotherapy for people with Parkinson·s disease: UK Plant R ( 2000

 ) Physiotherapy for people with Parkinson·s disease: UK best practicebest practiceshort report, Institute of short report, Institute of RehabilitiationRehabilitiation, University of Northumbria, Newcastle, University of Northumbria, Newcastleupon Tyne.upon Tyne.

Rescue ProjectRescue Project www.rescueproject.org/overview/welcome.htm www.rescueproject.org/overview/welcome.htm

PoewePoewe WH, WH, Wenning  Wenning GK. The natural history of Parkinson·s disease.GK. The natural history of Parkinson·s disease.  Ann Ann NeurolNeurol1998 Sep;44(31998 Sep;44(3 SupplSuppl 1 ):S11 ):S1--S9.S9.

Pressley JC, Louis ED, Tang MX, et al. The impact of Pressley JC, Louis ED, Tang MX, et al. The impact of comorbidity comorbidity diseasedisease andandinjuries on resource use and expenditures ininjuries on resource use and expenditures in parkinsonism.Neurology parkinsonism.Neurology 2003;60:872003;60:87²  ²93. 9393. 93

Reuter I,Reuter I, EngelhardtEngelhardt M,M, SteckerStecker K, Baas H. Therapeutic value of exercise training inK, Baas H. Therapeutic value of exercise training in

Parkinson·s disease. MedParkinson·s disease. Med SciSci Sports Exerc1999 Nov;31:1544Sports Exerc1999 Nov;31:1544--9 patients.9 patients.NeuroRehabilitationNeuroRehabilitation 2002;17( 2 ):1612002;17( 2 ):161--8.8.

REFERENCESREFERENCES ScandalisScandalis T A, T A, Bosak Bosak A, Berliner JC, A, Berliner JC, HelmanHelman LL, WellsLL, Wells

Page 183: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 183/186

,, , J ,, J , ,,

MR.ResistanceMR.Resistance training and gait function intraining and gait function inpatientspatients withParkinson·s withParkinson·s disease.  Am J Phys Meddisease.  Am J Phys Med

RehabilRehabil 2001 Jan;80( 1 ):382001 Jan;80( 1 ):38--43.43.

SchenkmanSchenkman M et al ( 1

989) ¶Management of individualsM et al ( 1

989) ¶Management of individuals with Parkinson·s disease: Rationale and case study· with Parkinson·s disease: Rationale and case study·

Physical Therapy 69(11),944Physical Therapy 69(11),944²  ²955 955 

StallibrassStallibrass C ( 1997) ¶ An evaluation of the  AlexanderC ( 1997) ¶ An evaluation of the  Alexander

technique for the management of disability intechnique for the management of disability inParkinson·s diseaseParkinson·s disease ²  ² a preliminary a preliminary Reha b ilitation Reha b ilitation 

11,8 11,8²  ²12 12 

REFERENCEREFERENCE SchenkmanSchenkman M,M, CutsonCutson TM, TM, KuchibhatlaKuchibhatla M, ChandlerM, Chandler

JM PiJM Pi CF R L t l E i t iCF R L t l E i t i

Page 184: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 184/186

 JM,Pieper JM,Pieper CF, Ray L, et al. Exercise to improveCF, Ray L, et al. Exercise to improve

spinal flexibility and function for people withspinal flexibility and function for people with Parkinson·sParkinson·sdisease: adisease: a randomized,controlledrandomized,controlled trial. J  Amtrial. J  Am GeriatrGeriatr SocSoc1998;46:12071998;46:1207--16.16.

Schrag Schrag A, A, Jahanshahi Jahanshahi M, Quinn N. How doesM, Quinn N. How doesParkinson·sParkinson·s diseaseaffectdiseaseaffect quality of life?  A quality of life?  A comparisoncomparison with quality of life in the general population. with quality of life in the general population. Mov Mov DisordDisord2000;15:11122000;15:1112 ²  ² 11181118

Schrag Schrag A, A, Jahanshahi Jahanshahi M, Quinn N. What contributes tM, Quinn N. What contributes toquality oquality of life in patients with Parkinson·sof life in patients with Parkinson·s disease? Jdisease? JNeurolNeurosurg NeurolNeurosurg Psychiatry  2000;69(308):312.Psychiatry  2000;69(308):312.

REFERENCEREFERENCE Schultz JH,Schultz JH, LutheLuthe W.  Autogenic therapy methods. New  W.  Autogenic therapy methods. New York:Gruen York:Gruen andand

Stratton. New York:Stratton. New York: GruenGruen and Stratton; 1969.and Stratton; 1969.

ll l bl b kk l l f d dl l f d d

Page 185: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 185/186

StolzeStolze H,H, KlebeKlebe S,S, BaeckerBaecker C, et al. Prevalence of gait disorders inC, et al. Prevalence of gait disorders in

hospitalized neurological patients.hospitalized neurological patients. Mov Mov DisordDisord 2005;20:892005;20:89²  ²94.94.

 Thaut Thaut MH, McIntosh GC, Rice RR, Miller R  A,MH, McIntosh GC, Rice RR, Miller R  A, RathbunRathbun J,Brault J,Brault JM. JM.Rhythmic auditory stimulation in gait training Rhythmic auditory stimulation in gait training forParkinson·sforParkinson·sdisease patients.disease patients. Mov Mov DisordDisord 1996 Mar;11( 2 ):1931996 Mar;11( 2 ):193--200200

 Wenning  Wenning GK,GK, EbersbachEbersbach G,G, Verny  Verny M,M, ChaudhuriChaudhuri KR,JellingerKR,Jellinger K,K,McKee  A, et al. Progression of falls inMcKee  A, et al. Progression of falls in postmortempostmortem--ConfirmedConfirmedparkinsonianparkinsonian disorders.disorders. Mov Mov DisordDisord 1999Nov;14( 6 ):9471999Nov;14( 6 ):947--50.50.

 World Health Organisation ( 1980 ) The international classification of  World Health Organisation ( 1980 ) The international classification of 

impairments,disabilitiesimpairments,disabilities and handicapsand handicaps ²  ² A

manual of  A

manual of classificationclassificationrelating relating to the consequences of disease. Geneva; WHOto the consequences of disease. Geneva; WHO

Page 186: Irogue Seminar Presentation October 2010

8/3/2019 Irogue Seminar Presentation October 2010

http://slidepdf.com/reader/full/irogue-seminar-presentation-october-2010 186/186

 THANK YOU VERY MUCH FOR YOUR ATTENTION

QUESTIONS AND COMMENTQUESTIONS AND COMMENT..